<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Biomolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id><journal-id journal-id-type="publisher-id">biomolecules</journal-id><journal-title-group><journal-title>Biomolecules</journal-title></journal-title-group><issn pub-type="epub">2218-273X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38397443</article-id><article-id pub-id-type="pmc">10887155</article-id><article-id pub-id-type="doi">10.3390/biom14020206</article-id><article-id pub-id-type="publisher-id">biomolecules-14-00206</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1528-6625</contrib-id><name><surname>Gr&#xFC;ning</surname><given-names>Nana-Maria</given-names></name><xref rid="af1-biomolecules-14-00206" ref-type="aff">1</xref><xref rid="c1-biomolecules-14-00206" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9535-7413</contrib-id><name><surname>Ralser</surname><given-names>Markus</given-names></name><xref rid="af1-biomolecules-14-00206" ref-type="aff">1</xref><xref rid="af2-biomolecules-14-00206" ref-type="aff">2</xref><xref rid="af3-biomolecules-14-00206" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Di Domenico</surname><given-names>Fabio</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-biomolecules-14-00206"><label>1</label>Department of Biochemistry, Charit&#xE9; Universit&#xE4;tsmedizin Berlin, 10117 Berlin, Germany; <email>markus.ralser@charite.de</email></aff><aff id="af2-biomolecules-14-00206"><label>2</label>The Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK</aff><aff id="af3-biomolecules-14-00206"><label>3</label>Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany</aff><author-notes><corresp id="c1-biomolecules-14-00206"><label>*</label>Correspondence: <email>nanam.gruening@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>2</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2024</year></pub-date><volume>14</volume><issue>2</issue><elocation-id>206</elocation-id><history><date date-type="received"><day>01</day><month>1</month><year>2024</year></date><date date-type="rev-recd"><day>25</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>01</day><month>2</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Oxidative stress, characterized by an imbalance between the production of reactive oxygen species (ROS) and the cellular anti-oxidant defense mechanisms, plays a critical role in the pathogenesis of various human diseases. Redox metabolism, comprising a network of enzymes and genes, serves as a crucial regulator of ROS levels and maintains cellular homeostasis. This review provides an overview of the most important human genes encoding for proteins involved in ROS generation, ROS detoxification, and production of reduced nicotinamide adenine dinucleotide phosphate (NADPH), and the genetic disorders that lead to dysregulation of these vital processes. Insights gained from studies on inherited monogenic metabolic diseases provide valuable basic understanding of redox metabolism and signaling, and they also help to unravel the underlying pathomechanisms that contribute to prevalent chronic disorders like cardiovascular disease, neurodegeneration, and cancer.</p></abstract><kwd-group><kwd>oxidative stress</kwd><kwd>reactive oxygen species (ROS)</kwd><kwd>cellular redox balance</kwd><kwd>monogenic disorder</kwd><kwd>inherited disease</kwd></kwd-group><funding-group><award-group><funding-source>Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)</funding-source><award-id>CRC-TRR186</award-id></award-group><funding-statement>M.R. acknowledges support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the CRC-TRR186, &#x2018;Molecular Switches&#x2019;.</funding-statement></funding-group></article-meta></front>
  <body>
    <sec sec-type="intro" id="sec1-biomolecules-14-00206">
      <title>1. Introduction</title>
      <p>Reactive oxygen species (ROS, [<xref rid="B1-biomolecules-14-00206" ref-type="bibr">1</xref>]) are formed by incomplete reduction of oxygen, and comprise a variety of highly reactive, oxygen-containing compounds, with the superoxide anion radical (O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and the hydroxyl radical (OH<bold><sup>&#xB7;</sup></bold>) being the most prominent types in aerobic organisms [<xref rid="B2-biomolecules-14-00206" ref-type="bibr">2</xref>]. ROS can be subdivided into free radicals and nonradicals. The former carry an unpaired electron (e.g., O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup>, OH<bold><sup>&#xB7;</sup></bold>) and can combine to form nonradicals (e.g., H<sub>2</sub>O<sub>2</sub>) [<xref rid="B3-biomolecules-14-00206" ref-type="bibr">3</xref>]. Cells can experience ROS exposure either through their production by endogenous systems or through external perturbations. At physiological concentrations, ROS serve important functions.For example, H<sub>2</sub>O<sub>2</sub> acts as a second messenger to communicate pro-inflammatory and growth-stimulating signals [<xref rid="B4-biomolecules-14-00206" ref-type="bibr">4</xref>,<xref rid="B5-biomolecules-14-00206" ref-type="bibr">5</xref>,<xref rid="B6-biomolecules-14-00206" ref-type="bibr">6</xref>]. Furthermore, ROS are also employed in the defense against pathogens when immune cells produce high levels of O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> or H<sub>2</sub>O<sub>2</sub> to kill bacteria or fungi [<xref rid="B7-biomolecules-14-00206" ref-type="bibr">7</xref>].</p>
      <p>However, in order to stabilize themselves, ROS take up electrons and oxidize, and thereby unspecifically damage biomolecules such as nucleic acids, metabolites, lipids, and proteins. In order to keep oxidative damage low, cells have evolved anti-oxidative defense systems. When the level of ROS overflows the capacity of these defense mechanisms, oxidative stress occurs, with the redox balance of the cell, or of its different compartments, shifting away from the physiologically ideal state. If this deviation is strong, disruption of cellular processes may occur [<xref rid="B8-biomolecules-14-00206" ref-type="bibr">8</xref>]. Hence, oxidative stress has implications in various human diseases such as cancer, stroke, or late-onset neurodegenerative disorders caused by environmental stresses or congenital dysfunction of the proteins involved in redox balance [<xref rid="B9-biomolecules-14-00206" ref-type="bibr">9</xref>]. </p>
      <p>When endogenous ROS production or the anti-oxidative machinery are inherently impaired, the cell has limited capacities to tackle oxidative stress from the start. In this review, we summarize the main monogenic disorders that are caused by germline pathogenic variants in genes that are part of endogenous ROS production and the primary anti-oxidative defense machinery. Our emphasis is on the initial encounters of cells with ROS, encompassing ROS production, scavenging, and the recycling of ROS scavengers. While repair mechanisms for damaged biomolecules associated with prolonged adaptation to oxidative stress are vital components, their abundance demands dedicated exploration beyond the scope of this review. </p>
      <p>This overview of monogenic disorders related to ROS production and the primary anti-oxidative defense encompasses a spectrum ranging from prevalent enzymopathies to some of the rarest inherited disorders. Putting the spotlight onto these rare enzymopathies describes the intricacies of redox metabolism and might inspire more research attention to underexplored diseases. </p>
    </sec>
    <sec id="sec2-biomolecules-14-00206">
      <title>2. Sources of ROS </title>
      <p>ROS are either produced through cellular processes or environmental factors. Of note, oxidative stress has been described as a secondary effect within the pathology of several rare monogenic diseases and sometimes been called a common denominator [<xref rid="B10-biomolecules-14-00206" ref-type="bibr">10</xref>,<xref rid="B11-biomolecules-14-00206" ref-type="bibr">11</xref>]. For example, the Friedreich&#x2019;s ataxia protein FXN was shown to play a role in mitochondria biogenesis [<xref rid="B12-biomolecules-14-00206" ref-type="bibr">12</xref>] and iron&#x2013;sulfur cluster synthesis [<xref rid="B13-biomolecules-14-00206" ref-type="bibr">13</xref>]. Via these functions, mutation of FXN leads to oxidative stress, which contributes to the pathology of Friedreich&#x2019;s ataxia [<xref rid="B14-biomolecules-14-00206" ref-type="bibr">14</xref>]. Such effects in which oxidative stress appears as a molecular symptom of the original genetic disruption have been extensively discussed elsewhere (e.g., [<xref rid="B10-biomolecules-14-00206" ref-type="bibr">10</xref>,<xref rid="B15-biomolecules-14-00206" ref-type="bibr">15</xref>,<xref rid="B16-biomolecules-14-00206" ref-type="bibr">16</xref>,<xref rid="B17-biomolecules-14-00206" ref-type="bibr">17</xref>]). Herein, we focus on pathogenic genetic variants that affect the main genes directly responsible for internal ROS production and hence have the immediate ability to cause oxidative imbalance in either direction and impair physiological function. </p>
      <sec id="sec2dot1-biomolecules-14-00206">
        <title>2.1. The Mitochondrial Respiratory Chain</title>
        <p>The mitochondrial respiratory chain, or electron transport chain (ETC), is one of the biggest endogenous sources of ROS in eukaryotic cells which use aerobic metabolism (<xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B18-biomolecules-14-00206" ref-type="bibr">18</xref>,<xref rid="B19-biomolecules-14-00206" ref-type="bibr">19</xref>]. In humans, the enzyme complexes I (NADH:ubiquinone oxidoreductase), II (succinate:ubiquinone oxidoreductase), and III (ubiquinol:cytochrome c oxidoreductase) are somewhat &#x201C;leaky&#x201D;, leading to direct one-electron transfer to molecular oxygen and the perpetual production of the superoxide anion radical (O<sub>2&#xB7;&#x2212;</sub>) as side reactions [<xref rid="B19-biomolecules-14-00206" ref-type="bibr">19</xref>,<xref rid="B20-biomolecules-14-00206" ref-type="bibr">20</xref>].</p>
        <p>Complex I is encoded by more than 40 genes [<xref rid="B21-biomolecules-14-00206" ref-type="bibr">21</xref>], complex II by four genes [<xref rid="B22-biomolecules-14-00206" ref-type="bibr">22</xref>] and complex III by 11 genes [<xref rid="B23-biomolecules-14-00206" ref-type="bibr">23</xref>]. However, the specific sites and levels of ROS production within the different protein complexes depend on the respiration substrate, whether the cell experiences norm- or hypoxic conditions, and on the inhibitor used in experimental setups [<xref rid="B24-biomolecules-14-00206" ref-type="bibr">24</xref>]. Furthermore, respiratory complexes can assemble into supercomplexes, which decreases ROS production [<xref rid="B25-biomolecules-14-00206" ref-type="bibr">25</xref>]. Astrocytes contain high amounts of free complex I and thus potentially higher levels of ROS compared to neurons, which display complex I and III assembly [<xref rid="B26-biomolecules-14-00206" ref-type="bibr">26</xref>]. Thus, the diversity of conditions as well as of cell type specificities make it often hard to pin down the specific set of genes of respiratory complex subunits which involve pathomechanisms related to ROS production in humans. This is also exemplified by the fact that some pathogenic mutations within subunits do not lead to ROS elevation, as shown for H<sub>2</sub>O<sub>2</sub> in a mouse model for Leigh syndrome [<xref rid="B27-biomolecules-14-00206" ref-type="bibr">27</xref>]. By contrast, in other experiments, mutations of genes involved in complex I, II, or III formation were indeed shown to create greater &#x201C;leakiness&#x201D;, and cause elevated ROS levels and oxidative stress [<xref rid="B21-biomolecules-14-00206" ref-type="bibr">21</xref>,<xref rid="B28-biomolecules-14-00206" ref-type="bibr">28</xref>,<xref rid="B29-biomolecules-14-00206" ref-type="bibr">29</xref>,<xref rid="B30-biomolecules-14-00206" ref-type="bibr">30</xref>]. </p>
        <p>Since the ETC generates a strong proton gradient used for oxidative phosphorylation, transport processes, and heat production, it can be difficult to disentangle whether the pathophysiological mechanism triggered by mutation of ETC genes is based on compromised primary functions, or elevated ROS levels. However, at least for complex I deficiency, elevated ROS production and its consequent oxidative damage were shown to induce apoptotic molecular pathways leading to neuron degeneration and hence neurological symptoms, the main features of the disorder [<xref rid="B28-biomolecules-14-00206" ref-type="bibr">28</xref>].</p>
        <p>Deficiencies in respiratory complexes have similar but wide-ranging symptoms from neonatal death, lactic acidosis, myopathy, hepatopathy, encephalopathy, Leigh syndrome [<xref rid="B31-biomolecules-14-00206" ref-type="bibr">31</xref>], Leber hereditary optic neuropathy (LHON) [<xref rid="B32-biomolecules-14-00206" ref-type="bibr">32</xref>], to adult-onset neurological symptoms such as some forms of Parkinson disease [<xref rid="B33-biomolecules-14-00206" ref-type="bibr">33</xref>,<xref rid="B34-biomolecules-14-00206" ref-type="bibr">34</xref>]. Isolated complex I deficiency is the most prevalent genetic disorder of oxidative phosphorylation [<xref rid="B35-biomolecules-14-00206" ref-type="bibr">35</xref>]. </p>
        <p>As outlined above, it is challenging to disentangle the underlying factors, but the numerous potential ROS production sites and levels might be part of the explanation of the broad range of symptoms and disorder severities. </p>
      </sec>
      <sec id="sec2dot2-biomolecules-14-00206">
        <title>2.2. Heme in Red Blood Cells</title>
        <p>Another ROS formation hotspot, despite being devoid of mitochondria, is the cytosol of red blood cells (RBCs). RBCs transport oxygen from the lung to peripheral tissues and superoxide can be formed when O<sub>2</sub> interacts with the iron (Fe<sup>2+</sup>) of the heme group of hemoglobin (Hb) [<xref rid="B36-biomolecules-14-00206" ref-type="bibr">36</xref>]. Spontaneous autoxidation results in O<sup>2&#xB7;&#x2212;</sup> and methemoglobin (Hb-Fe<sup>3+</sup>, MetHb, Hb M) (<xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B35-biomolecules-14-00206" ref-type="bibr">35</xref>,<xref rid="B37-biomolecules-14-00206" ref-type="bibr">37</xref>], and ca. 1% of all Hb is present as Hb M in healthy individuals [<xref rid="B38-biomolecules-14-00206" ref-type="bibr">38</xref>].</p>
        <p>This normally occurring rate of superoxide production can be exceeded by pathogenic genetic variants that cause conformational changes to the globin chain proteins that contain heme as a prosthetic group. This phenomenon is well described for, e.g., autosomal recessive sickle cell disease (SCD) (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>). SCD is the most common severe hemoglobinopathy worldwide and is caused by a missense pathogenic variant in the globin beta-chain (<italic toggle="yes">HBB</italic>), resulting in Hb S (NM_000518.5(<italic toggle="yes">HBB</italic>):c.20A&gt;T (p.Glu7Val); E6V) [<xref rid="B39-biomolecules-14-00206" ref-type="bibr">39</xref>], which is unstable, prone to polymerization and autoxidation [<xref rid="B40-biomolecules-14-00206" ref-type="bibr">40</xref>]. Besides other ROS sources like iron release, this autoxidation is the primary source for oxidative stress in sickle cells, and it leads to loss of membrane structure and function and consequent multisystem disease [<xref rid="B41-biomolecules-14-00206" ref-type="bibr">41</xref>,<xref rid="B42-biomolecules-14-00206" ref-type="bibr">42</xref>,<xref rid="B43-biomolecules-14-00206" ref-type="bibr">43</xref>,<xref rid="B44-biomolecules-14-00206" ref-type="bibr">44</xref>]. When iron is released, it impacts the oxidative balance through transfer of single electrons via the Fenton reaction (Fe<sup>2+</sup> + H<sub>2</sub>O<sub>2</sub> &#x2192; Fe<sup>3+</sup> + HO<bold><sup>&#xB7;</sup></bold> + OH<sup>&#x2212;</sup>) and the Haber&#x2013;Weiss reaction (O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> + H<sub>2</sub>O<sub>2</sub> &#x2192; O<sub>2</sub> + HO<bold><sup>&#xB7;</sup></bold> + OH<sup>&#x2212;</sup> catalyzed by iron) (<xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B45-biomolecules-14-00206" ref-type="bibr">45</xref>].</p>
        <p>Also, other <italic toggle="yes">HBB</italic> variants have been described to cause methemoglobinemia. For example, the so-called Hb M-Hyde Park (Hb M-Akita) (NM_000518.4(<italic toggle="yes">HBB</italic>):c.277C&gt;T (p.His93Tyr)) variant leads to conformational changes at the heme binding site and hence higher rates of methemoglobin formation. Inheritance is autosomal dominant [<xref rid="B38-biomolecules-14-00206" ref-type="bibr">38</xref>,<xref rid="B46-biomolecules-14-00206" ref-type="bibr">46</xref>]. </p>
      </sec>
      <sec id="sec2dot3-biomolecules-14-00206">
        <title>2.3. NADPH Oxidases and Myeloperoxidase</title>
        <p>Besides these cellular processes in which ROS are formed passively as byproducts, the cell can actively produce high levels of ROS through dedicated enzymes. NADPH oxidases (NOX) use reduced nicotinamide adenine dinucleotide phosphate (NADPH) to generate superoxide (<xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B47-biomolecules-14-00206" ref-type="bibr">47</xref>]. NOX play an important role in the innate host defense. For the so-called &#x201C;respiratory burst&#x201D;, superoxide is released into the extracellular space or phagosomes to fight off pathogenic bacteria or fungi [<xref rid="B48-biomolecules-14-00206" ref-type="bibr">48</xref>]. Furthermore, NOX enzymes were found to produce intracellular ROS at lower levels, which is believed to serve signaling functions [<xref rid="B49-biomolecules-14-00206" ref-type="bibr">49</xref>] and to control the cellular redox balance by oxidizing NADPH and through ROS formation [<xref rid="B50-biomolecules-14-00206" ref-type="bibr">50</xref>]. The importance of the ability to generate high ROS levels is exemplified by the detrimental consequences of NOX disruption.</p>
        <p>Several monogenic disorders are related to NOX subunits. The genes that encode the NOX2 complex in phagocytes are related to chronic granulomatous disease [<xref rid="B51-biomolecules-14-00206" ref-type="bibr">51</xref>,<xref rid="B52-biomolecules-14-00206" ref-type="bibr">52</xref>]: <italic toggle="yes">CYBB</italic> pathogenic variants cause X-linked recessive chronic granulomatous disease (CGDX, [<xref rid="B53-biomolecules-14-00206" ref-type="bibr">53</xref>]) and immunodeficiency 34 [<xref rid="B54-biomolecules-14-00206" ref-type="bibr">54</xref>]), <italic toggle="yes">CYBA</italic> pathogenic variants cause autosomal recessive (AR) CGD4 [<xref rid="B55-biomolecules-14-00206" ref-type="bibr">55</xref>], <italic toggle="yes">NCF1</italic> pathogenic variants cause AR CGD1 [<xref rid="B56-biomolecules-14-00206" ref-type="bibr">56</xref>], <italic toggle="yes">NCF2</italic> pathogenic variants cause AR CGD2 [<xref rid="B57-biomolecules-14-00206" ref-type="bibr">57</xref>], and <italic toggle="yes">NCF4</italic> pathogenic variants cause AR CGD3 [<xref rid="B58-biomolecules-14-00206" ref-type="bibr">58</xref>] (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>). These rare primary immunodeficiencies increase susceptibility to life-threatening bacterial and fungal infections and lead to development of granulomas [<xref rid="B59-biomolecules-14-00206" ref-type="bibr">59</xref>]. </p>
        <p>Pathogenic variants in other NADPH oxidases were shown to increase susceptibility to inflammatory bowel disease (<italic toggle="yes">NOX1</italic> and <italic toggle="yes">DUOX2</italic>, [<xref rid="B60-biomolecules-14-00206" ref-type="bibr">60</xref>]), or cause congenital hypothyroidism (<italic toggle="yes">DUOX2</italic>, Thyroid dyshormonogenesis 6, AR, [<xref rid="B61-biomolecules-14-00206" ref-type="bibr">61</xref>]; <italic toggle="yes">DUOXA2</italic>, Thyroid dyshormonogenesis 5, AR, [<xref rid="B62-biomolecules-14-00206" ref-type="bibr">62</xref>], <xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>). The latter one is the result of disrupted H<sub>2</sub>O<sub>2</sub> production through mutated DUOX2, which would be required for organification of iodide for thyroid hormone synthesis catalyzed by thyroid peroxidase [<xref rid="B52-biomolecules-14-00206" ref-type="bibr">52</xref>,<xref rid="B63-biomolecules-14-00206" ref-type="bibr">63</xref>].</p>
        <p>Another enzyme of the innate immune response is the heme-containing enzyme myeloperoxidase (MPO, <xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>, <xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>). It is highly abundant in azurophilic granules of neutrophils [<xref rid="B64-biomolecules-14-00206" ref-type="bibr">64</xref>] and is a crucial component in neutrophil extracellular nets [<xref rid="B65-biomolecules-14-00206" ref-type="bibr">65</xref>]; it is also found&#x2014;to a lesser extent&#x2014;in monocytes [<xref rid="B66-biomolecules-14-00206" ref-type="bibr">66</xref>]. To kill pathogens, MPO creates strongly reactive species, such as hypochlorous acid (HOCl<sup>.</sup>) from hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and chloride (Cl<sup>&#x2212;</sup>) [<xref rid="B67-biomolecules-14-00206" ref-type="bibr">67</xref>,<xref rid="B68-biomolecules-14-00206" ref-type="bibr">68</xref>]. Autosomal recessive MPO deficiency is the most common phagocyte defect but is asymptomatic in the majority of patients, suggesting compensatory mechanisms [<xref rid="B69-biomolecules-14-00206" ref-type="bibr">69</xref>]. However, higher susceptibility to fungal infections, especially <italic toggle="yes">Candida albicans</italic>, has been described [<xref rid="B70-biomolecules-14-00206" ref-type="bibr">70</xref>]. This vulnerability might become apparent only in combination with comorbidities like diabetes, which itself increases the risk of infections [<xref rid="B68-biomolecules-14-00206" ref-type="bibr">68</xref>]. Similarly, a recent study described a case of partial DiGeorge syndrome together with MPO deficiency. DiGeorge syndrome is characterized by immunodeficiency among other symptoms. However, the patient had more frequent and severe infections than expected for partial DiGeorge alone, which the authors explained by co-occurrence of MPO deficiency [<xref rid="B71-biomolecules-14-00206" ref-type="bibr">71</xref>]. On the other hand, a protective mechanism against cardiovascular disease by absence of the potentially oxidative stress causing MPO enzyme has also been discussed [<xref rid="B69-biomolecules-14-00206" ref-type="bibr">69</xref>]. </p>
      </sec>
      <sec id="sec2dot4-biomolecules-14-00206">
        <title>2.4. Other ROS Sources </title>
        <p>In addition to the above-described reactions and enzymes, there are additional sources that can produce significant amounts of reactive species under certain physiological circumstances. </p>
        <p>For example, xanthine oxidoreductase (XDH/XOD), encoded by the <italic toggle="yes">XDH</italic> gene (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>, <xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>), exists in two interconvertible isoforms. Both forms utilize hypoxanthine or xanthine to produce uric acid. However, the predominant form has xanthine dehydrogenase (XDH) activity, and uses NAD<sup>+</sup> as cofactor to produce NADH, whereas the xanthine oxidase (XOD) form uses oxygen to produce the superoxide anion and H<sub>2</sub>O<sub>2</sub> [<xref rid="B72-biomolecules-14-00206" ref-type="bibr">72</xref>]. XDH can be converted to XOD by irreversible limited proteolysis or reversibly by thiol oxidation (reviewed in [<xref rid="B73-biomolecules-14-00206" ref-type="bibr">73</xref>]), e.g., in hypoxic/ischemic tissue [<xref rid="B74-biomolecules-14-00206" ref-type="bibr">74</xref>]. Homozygous or compound heterozygous pathogenic <italic toggle="yes">XDH</italic> variants cause type I xanthinuria (XAN1) [<xref rid="B75-biomolecules-14-00206" ref-type="bibr">75</xref>]. The symptoms, low serum and urine uric acid and xanthinuria leading to urolithiasis [<xref rid="B76-biomolecules-14-00206" ref-type="bibr">76</xref>], result from XDH&#x2019;s primary function. Mutations that lead to elevated ROS production are not described for this enzyme to the best of our knowledge. </p>
        <p>Furthermore, nitric oxide synthases (NOS1-3) can become sources of O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> (<xref rid="biomolecules-14-00206-f001" ref-type="fig">Figure 1</xref>). Normally, they use L-arginine to produce nitric oxide (&#xB7;NO), which belongs to the group of reactive nitrogen species (RNS) and serves as an important signaling molecule, especially for the vascular tone [<xref rid="B77-biomolecules-14-00206" ref-type="bibr">77</xref>]. However, persistent oxidative stress, and thus reduced levels of the cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (BH<sub>4</sub>), lead to uncoupling of endothelial NOS (eNOS, NOS3) so that the enzyme produces O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> instead of &#xB7;NO [<xref rid="B78-biomolecules-14-00206" ref-type="bibr">78</xref>]. Furthermore, O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> is produced by NOS2 in arginine-depleted macrophages [<xref rid="B79-biomolecules-14-00206" ref-type="bibr">79</xref>]. Although some <italic toggle="yes">NOS3</italic> variants have been described to increase the risk for certain conditions like pregnancy- induced hypertension [<xref rid="B80-biomolecules-14-00206" ref-type="bibr">80</xref>] or ischemic stroke [<xref rid="B81-biomolecules-14-00206" ref-type="bibr">81</xref>], no clear monogenic disorder has been described for <italic toggle="yes">NOS1</italic>, <italic toggle="yes">NOS2</italic>, or <italic toggle="yes">NOS3</italic>.</p>
        <p>At lower amounts, ROS can also be byproducts of other enzymes like cytochrome P450 or cyclooxygenase (reviewed in [<xref rid="B82-biomolecules-14-00206" ref-type="bibr">82</xref>]). </p>
        <p>Environmental factors that create elevated ROS levels are, e.g., UV radiation, ionizing radiation, smoking and air pollution, chemicals such as drugs, and certain types of food like the fava bean [<xref rid="B2-biomolecules-14-00206" ref-type="bibr">2</xref>,<xref rid="B83-biomolecules-14-00206" ref-type="bibr">83</xref>]. Often, genetic defects in the anti-oxidative machinery remain unnoticed until such environmental stresses hit and overwhelm the residual anti-oxidative capacity of the cell, e.g., in hemolytic anemia due to glucose 6-phosphate dehydrogenase (G6PDH) deficiency (see below).</p>
      </sec>
    </sec>
    <sec id="sec3-biomolecules-14-00206">
      <title>3. The Anti-Oxidative Defense System</title>
      <p>Protective mechanisms have evolved that keep the redox balance in check or clear ROS-induced damage. There are several ways to categorize the different parts of the overall cellular anti-oxidative defense system. Ighodaro and Akinloye [<xref rid="B84-biomolecules-14-00206" ref-type="bibr">84</xref>] propose to categorize the individual parts of the anti-oxidative machinery into first, second, third, and fourth line defense. </p>
      <p>First line antioxidants prevent or reduce ROS formation. The most important agents in this category are superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and peroxiredoxins (PRDX). SOD dismutates the superoxide anion O<sup>2&#xB7;&#x2212;</sup> to H<sub>2</sub>O<sub>2</sub>, and CAT detoxifies H<sub>2</sub>O<sub>2</sub> to water and oxygen. GPX and PRDX convert H<sub>2</sub>O<sub>2</sub> to water, are oxidized themselves, and need to be reduced again to stay functional (<xref rid="biomolecules-14-00206-f002" ref-type="fig">Figure 2</xref>, [<xref rid="B3-biomolecules-14-00206" ref-type="bibr">3</xref>]). Second-line anti-oxidants act as so-called &#x201C;scavengers&#x201D; and prevent ROS from damaging biomolecules or forming further ROS. These are either small, non-enzyme molecules that are produced by human cells, like glutathione (GSH), uric acid, and ubiquinol, or proteins with thiol groups like thioredoxins (TXN) or peroxiredoxins [<xref rid="B85-biomolecules-14-00206" ref-type="bibr">85</xref>,<xref rid="B86-biomolecules-14-00206" ref-type="bibr">86</xref>]. Also, nitric oxide (&#xB7;NO) falls into this category as it scavenges O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> to form peroxynitrite (ONOO<sup>&#x2212;</sup>), which itself is highly reactive at physiological pH and needs to be further converted, e.g., by GSH [<xref rid="B87-biomolecules-14-00206" ref-type="bibr">87</xref>]. Scavengers can also be small molecules taken up by nutrition, like ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E). Third-line anti-oxidants repair already damaged structures, and fourth-line anti-oxidants build up prevention and adaptation mechanisms, e.g., upregulate expression of relevant genes [<xref rid="B84-biomolecules-14-00206" ref-type="bibr">84</xref>] or, even faster, metabolic switches like the inactivation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which leads to metabolic rerouting into the pentose phosphate pathway and increased NADPH production [<xref rid="B88-biomolecules-14-00206" ref-type="bibr">88</xref>,<xref rid="B89-biomolecules-14-00206" ref-type="bibr">89</xref>]. </p>
      <p>First- and second-line defense can be summarized as primary anti-oxidative defense, which serves for immediate protection [<xref rid="B90-biomolecules-14-00206" ref-type="bibr">90</xref>]. Within the primary antioxidative defense, the thiols GSH and TXN play crucial roles. The tripeptide GSH scavenges ROS or, like the polypeptide TXN, serves as an electron donor for peroxidases. The peroxidases either detoxify H<sub>2</sub>O<sub>2</sub> (GPX) or reduce oxidized cysteine residues and cleave ROS-caused disulfide bonds in proteins. In order to maintain a constant pool of reduced GSH and TXN, respective reductases recycle GSH and TXN under consumption of NADPH (<xref rid="biomolecules-14-00206-f002" ref-type="fig">Figure 2</xref>) [<xref rid="B91-biomolecules-14-00206" ref-type="bibr">91</xref>,<xref rid="B92-biomolecules-14-00206" ref-type="bibr">92</xref>]. </p>
      <sec id="sec3dot1-biomolecules-14-00206">
        <title>3.1. Enzymes of the ROS Scavenger System</title>
        <sec id="sec3dot1dot1-biomolecules-14-00206">
          <title>3.1.1. Superoxide Dismutases</title>
          <p>Three genes in humans (<italic toggle="yes">SOD1</italic>, <italic toggle="yes">SOD2</italic>, <italic toggle="yes">SOD3</italic>) encode for superoxide dismutases, of which only <italic toggle="yes">SOD1</italic> is described as disease associated. Amyotrophic lateral sclerosis (ALS) is a heterogenous, late-onset neurodegenerative disorder for which up to 95% of cases are sporadic. However, up to 10% of cases seem to have familial predisposition, and <italic toggle="yes">SOD1</italic> is a top hit among 40 associated genes. It is not unequivocally defined whether <italic toggle="yes">SOD1</italic> variants are causative for ALS, co-causative or modifying [<xref rid="B93-biomolecules-14-00206" ref-type="bibr">93</xref>], but hypothetical pathomechanisms explain the disease with mostly heterozygous gain-of-function variants that lead to the accumulation of aggregated SOD1 protein [<xref rid="B94-biomolecules-14-00206" ref-type="bibr">94</xref>,<xref rid="B95-biomolecules-14-00206" ref-type="bibr">95</xref>]. Elevated oxidative stress was also described in ALS, but it is not clear whether both mechanisms are linked [<xref rid="B96-biomolecules-14-00206" ref-type="bibr">96</xref>].</p>
          <p>Interestingly, more recently, homozygous <italic toggle="yes">SOD1</italic> variants were detected in children with progressive severe developmental delay, axial hypotonia, and spastic tetraplegia in at least three families. Biochemical testing confirmed total absence of enzyme activity in the patients and 50% of enzyme activity in the parents who were heterozygous for the respective familial variant [<xref rid="B97-biomolecules-14-00206" ref-type="bibr">97</xref>,<xref rid="B98-biomolecules-14-00206" ref-type="bibr">98</xref>,<xref rid="B99-biomolecules-14-00206" ref-type="bibr">99</xref>]. </p>
        </sec>
        <sec id="sec3dot1dot2-biomolecules-14-00206">
          <title>3.1.2. Catalase</title>
          <p>Once SOD has converted O<sup>2</sup><sup>&#xB7;&#x2212;</sup> into H<sub>2</sub>O<sub>2</sub>, the latter needs to be further detoxified. This task is efficiently accomplished by catalase that is encoded by the <italic toggle="yes">CAT</italic> gene, and which can convert millions of hydrogen peroxide molecules to water and oxygen per second [<xref rid="B100-biomolecules-14-00206" ref-type="bibr">100</xref>]. Homozygous pathogenic <italic toggle="yes">CAT</italic> variants are associated with the rare condition acatalasemia, also known as acatalasia, which leads to total or near total loss of CAT activity in erythrocytes [<xref rid="B101-biomolecules-14-00206" ref-type="bibr">101</xref>]. Probands with heterozygous variants are called hypocatalasemic and have blood catalase activity of about 50%. The disorder was coincidentally discovered by a Japanese doctor named Takahara in 1946, who performed oral surgery on a girl and used H<sub>2</sub>O<sub>2</sub> to disinfect the wound. He noticed the absence of oxygen bubbles that would normally be formed due to CAT activity. Additionally, the blood turned black [<xref rid="B102-biomolecules-14-00206" ref-type="bibr">102</xref>]. A dark chocolate brown color of arterial blood refers to methemoglobinemia [<xref rid="B103-biomolecules-14-00206" ref-type="bibr">103</xref>]&#x2014;the aforementioned phenomenon when some of the ferrous heme iron [Fe<sup>2+</sup>] is converted to ferric [Fe<sup>3+</sup>] iron in hemoglobin and hence oxygen transport is impaired. Takahara also described gangrenes, oral ulceration, and gingival necrosis in CAT-deficient patients. In the 1940s and 50s, oral hygiene was still poor in Japan and the symptoms were attributed to hydrogen peroxide produced by phagocytic cells and bacterial infections. When oral hygiene improved, these symptoms were seen less often. But besides these, the disorder used to be considered asymptomatic [<xref rid="B104-biomolecules-14-00206" ref-type="bibr">104</xref>]. However, animal models displayed a lower hydrogen peroxide removal rate and elevated oxidative stress. In fact, CAT-deficient patients develop diabetes more often and earlier, and it is known that insulin-producing pancreatic beta cells are especially vulnerable to oxidative damage. Indeed, acatalasemia and hypocatalasemic patients are prone to age- and oxidative stress-related diseases such as type II diabetes, tumors, Parkinson&#x2019;s disease, vitiligo, schizophrenia, or loss of soft tissues (reviewed in [<xref rid="B105-biomolecules-14-00206" ref-type="bibr">105</xref>,<xref rid="B106-biomolecules-14-00206" ref-type="bibr">106</xref>]). </p>
        </sec>
        <sec id="sec3dot1dot3-biomolecules-14-00206">
          <title>3.1.3. Glutathione Peroxidases</title>
          <p>Glutathione peroxidases (GSX) are a family of oxidoreductases that reduce H<sub>2</sub>O<sub>2</sub>, organic hydroperoxides and lipid peroxides by using GSH as a reductant. In humans, eight GPX enzymes are known to be encoded by the <italic toggle="yes">GPX1</italic>, <italic toggle="yes">GPX2</italic>, <italic toggle="yes">GPX3</italic>, <italic toggle="yes">GPX4</italic>, <italic toggle="yes">GPX5</italic>, <italic toggle="yes">GPX6</italic>, <italic toggle="yes">GPX7,</italic> and <italic toggle="yes">GPX8</italic> genes [<xref rid="B107-biomolecules-14-00206" ref-type="bibr">107</xref>]. Of these, <italic toggle="yes">GPX1</italic> and <italic toggle="yes">GPX4</italic> were mentioned in association with rare monogenic disorders. </p>
          <p>Biallelic pathogenic variants of <italic toggle="yes">GPX1</italic> have been described as associated with hemolytic anemia [<xref rid="B108-biomolecules-14-00206" ref-type="bibr">108</xref>]. Hemolysis due to lipid peroxidation is a well-described consequence of oxidative stress [<xref rid="B109-biomolecules-14-00206" ref-type="bibr">109</xref>]. However, a clear genotype&#x2013;phenotype relationship could not be unequivocally established to date. </p>
          <p>Biallelic pathogenic <italic toggle="yes">GPX4</italic> variants cause the rare and fatal disorder Sedaghatian type of spondylometaphyseal dysplasia (SSMD, [<xref rid="B110-biomolecules-14-00206" ref-type="bibr">110</xref>]), with only 24 cases described to date. SSMD is a severe metaphyseal chondrodysplasia with, e.g., delayed epiphyseal ossification, mild limb shortening, platyspondyly, pulmonary hemorrhage, and brain anomalies resulting in death due to respiratory failure or cardiac abnormalities in the perinatal period [<xref rid="B111-biomolecules-14-00206" ref-type="bibr">111</xref>]. Disruption of GPX4 causes buildup of lipid peroxidation and ferroptosis, which is an iron-dependent, non-apoptotic form of cell death [<xref rid="B112-biomolecules-14-00206" ref-type="bibr">112</xref>,<xref rid="B113-biomolecules-14-00206" ref-type="bibr">113</xref>]. </p>
        </sec>
        <sec id="sec3dot1dot4-biomolecules-14-00206">
          <title>3.1.4. Peroxiredoxins</title>
          <p>Peroxiredoxins are ubiquitous cysteine-containing proteins that are highly abundant, especially in RBCs, and play crucial roles in regulating intracellular peroxide levels [<xref rid="B114-biomolecules-14-00206" ref-type="bibr">114</xref>]. In humans, there are six genes: <italic toggle="yes">PRDX1</italic>, <italic toggle="yes">PRDX2</italic>, <italic toggle="yes">PRDX3</italic>, <italic toggle="yes">PRDX4</italic>, <italic toggle="yes">PRDX5,</italic> and <italic toggle="yes">PRDX6</italic>. Of these, <italic toggle="yes">PRDX1</italic>, <italic toggle="yes">PRDX2</italic> and <italic toggle="yes">PRDX4</italic>-<italic toggle="yes">6</italic> have not been described as related to a monogenic disorder. </p>
          <p>To the best of our knowledge, thus far, only <italic toggle="yes">PRDX3</italic>, which is localized to mitochondria [<xref rid="B115-biomolecules-14-00206" ref-type="bibr">115</xref>], is associated with monogenic disorders. In only eight cases, and rather recently, homozygous pathogenic <italic toggle="yes">PRDX3</italic> variants have been described to be causative for spinocerebellar ataxia-32 (SCAR32) [<xref rid="B116-biomolecules-14-00206" ref-type="bibr">116</xref>,<xref rid="B117-biomolecules-14-00206" ref-type="bibr">117</xref>,<xref rid="B118-biomolecules-14-00206" ref-type="bibr">118</xref>]. Patients presented with gait ataxia, cerebellar ataxia, upper limb ataxia, dysarthria, dysphagia, oculomotor signs, sometimes hyper- or hypokinetic movement abnormalities, and cerebellar atrophy in one patient. The disease mechanism was shown to be oxidative stress and mitochondrial damage due to absent or nearly absent expression of PRDX3 protein [<xref rid="B116-biomolecules-14-00206" ref-type="bibr">116</xref>,<xref rid="B118-biomolecules-14-00206" ref-type="bibr">118</xref>]. </p>
          <p>Heterozygous pathogenic <italic toggle="yes">PRDX3</italic> variants have been described in segregation studies as related to punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD). The phenotype, which was not reported in patients with homozygous pathogenic <italic toggle="yes">PRDX3</italic> variants, is characterized by hyperreflective deposits in the posterior stroma of the cornea of the eye. Affected individuals are asymptomatic with no visual impairment [<xref rid="B119-biomolecules-14-00206" ref-type="bibr">119</xref>,<xref rid="B120-biomolecules-14-00206" ref-type="bibr">120</xref>,<xref rid="B121-biomolecules-14-00206" ref-type="bibr">121</xref>].</p>
          <p><italic toggle="yes">PRDX1</italic> together with the <italic toggle="yes">MMACHC</italic> gene have been described as associated with the digenic disorder autosomal recessive combined methylmalonic aciduria and homocystinuria type cblC. <italic toggle="yes">PRDX1</italic> participates in the disease pathology by affecting <italic toggle="yes">MMACHC</italic> expression [<xref rid="B122-biomolecules-14-00206" ref-type="bibr">122</xref>]. </p>
        </sec>
      </sec>
      <sec id="sec3dot2-biomolecules-14-00206">
        <title>3.2. Electron Donors</title>
        <sec id="sec3dot2dot1-biomolecules-14-00206">
          <title>3.2.1. Glutathione </title>
          <p>GSH is a small tripeptide composed of cysteine, glutamate, and glycine. Due to the cysteine&#x2019;s thiol group, two GSH molecules can form a disulfide bond and thus serve as electron donors. GSH synthesis is catalyzed by the enzymes glutamate&#x2013;cysteine ligase (<italic toggle="yes">GCLC</italic>, catalytic subunit, &#x3B3;-glutamylcysteine synthetase) and glutathione synthetase (<italic toggle="yes">GSS</italic>), which are part of the &#x3B3;-glutamyl cycle [<xref rid="B123-biomolecules-14-00206" ref-type="bibr">123</xref>]. Pathogenic variants in both genes are described to be related to ultra-rare metabolic disorders. </p>
          <p>Glutamate&#x2013;cysteine ligase deficiency is an autosomal recessive disorder that is characterized by hemolytic anemia and variable other features like myopathy or late-onset spinocerebellar degeneration [<xref rid="B124-biomolecules-14-00206" ref-type="bibr">124</xref>]. Only very few patients have been described to date: five until 1996 and none more recently to our knowledge. The GSH content was very low in the RBCs of all five patients (between 2 and 13.1% of normal) [<xref rid="B125-biomolecules-14-00206" ref-type="bibr">125</xref>]. </p>
          <p>For glutathione synthetase deficiency, the OMIM database distinguishes between two forms: isolated hemolytic anemia [<xref rid="B126-biomolecules-14-00206" ref-type="bibr">126</xref>] and a severe, multi-tissue form characterized by hemolytic anemia, central nervous system symptoms (e.g., mental retardation, ataxia), metabolic acidosis and severe urinary excretion of 5-oxoproline [<xref rid="B127-biomolecules-14-00206" ref-type="bibr">127</xref>]. In the latter case, different cell types have severely reduced levels of enzyme activity and GSH content, whereas nucleated cells are able to maintain substantial levels of GSH in patients with isolated hemolytic anemia [<xref rid="B128-biomolecules-14-00206" ref-type="bibr">128</xref>]. It was proposed that accumulation of the GSS substrate &#x3B3;-glutamylcysteine substitutes GSH at least partially as an antioxidant [<xref rid="B129-biomolecules-14-00206" ref-type="bibr">129</xref>]. </p>
          <p>No null alleles have been described for both disorders; and complete absence of GSH due to <italic toggle="yes">Gclc</italic> or <italic toggle="yes">Gss</italic> knockout is lethal in mice [<xref rid="B130-biomolecules-14-00206" ref-type="bibr">130</xref>,<xref rid="B131-biomolecules-14-00206" ref-type="bibr">131</xref>,<xref rid="B132-biomolecules-14-00206" ref-type="bibr">132</xref>]. </p>
        </sec>
        <sec id="sec3dot2dot2-biomolecules-14-00206">
          <title>3.2.2. Thioredoxins</title>
          <p>Thioredoxins are small proteins that carry neighboring thiol groups in their active site that can form a disulfide bond and thereby serve as electron donors. Two thioredoxin genes have been described in humans: <italic toggle="yes">TXN</italic> (cytosolic) and <italic toggle="yes">TXN2</italic> (mitochondrial). <italic toggle="yes">Txn</italic> as well as <italic toggle="yes">Txn2</italic> knockout is embryonically lethal in mice [<xref rid="B133-biomolecules-14-00206" ref-type="bibr">133</xref>,<xref rid="B134-biomolecules-14-00206" ref-type="bibr">134</xref>]. </p>
          <p>While no genetic disorder has been described for <italic toggle="yes">TXN,</italic> the OMIM database mentions a phenotype named &#x201C;Combined oxidative phosphorylation deficiency 29&#x201D; (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) for <italic toggle="yes">TXN2</italic>. So far, only one patient with absent TXN2 protein in fibroblasts, disrupted ROS homeostasis, and impaired mitochondrial ATP generation due to a homozygous <italic toggle="yes">TXN2</italic> loss-of-function variant was identified by whole exome sequencing [<xref rid="B135-biomolecules-14-00206" ref-type="bibr">135</xref>]. These cellular phenotypes could be rescued by lentiviral expression of the wild-type TXN2 protein, and supplementation of antioxidants had beneficial effects on the patient&#x2019;s condition in short-term follow-up. The 16-year-old patient&#x2019;s main symptoms were microcephaly, optic atrophy, abnormal muscle tone, global developmental delay, seizures, cerebellar atrophy, spasticity, and increased serum lactate at the time [<xref rid="B135-biomolecules-14-00206" ref-type="bibr">135</xref>]. Nevertheless, the case remains interesting as no other pathogenic or likely pathogenic variant has been described for <italic toggle="yes">TXN2</italic>, and loss of TXN has been described as lethal in mice, which points to compensatory mechanisms in the patient described by Holzerova et al. [<xref rid="B135-biomolecules-14-00206" ref-type="bibr">135</xref>].</p>
        </sec>
        <sec id="sec3dot2dot3-biomolecules-14-00206">
          <title>3.2.3. Reductases for Recycling of Electron Donors</title>
          <p>Under constant ROS production, the pools of anti-oxidant electron donors would quickly deplete. Hence, reductases recycle the reduced forms of glutathione and thioredoxin, utilizing NADPH. </p>
          <sec>
            <title>Glutathione Reductase, GSR</title>
            <p>Glutathione reductase is encoded by only one gene in humans (<italic toggle="yes">GSR</italic>)<italic toggle="yes">,</italic> or mice (<italic toggle="yes">Gsr</italic>). Knockout of <italic toggle="yes">Gsr</italic> in mice results in a healthy phenotype [<xref rid="B136-biomolecules-14-00206" ref-type="bibr">136</xref>,<xref rid="B137-biomolecules-14-00206" ref-type="bibr">137</xref>]. However, homozygous pathogenic <italic toggle="yes">GSR</italic> variants in humans result in hemolytic anemia and cataract or hyperbilirubinemia and jaundice (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) [<xref rid="B138-biomolecules-14-00206" ref-type="bibr">138</xref>]. GSR activity was very low or absent in tested cells in patients from two families [<xref rid="B139-biomolecules-14-00206" ref-type="bibr">139</xref>,<xref rid="B140-biomolecules-14-00206" ref-type="bibr">140</xref>]. Normal glucose 6-phosphate dehydrogenase (G6PDH) activity, whose disruption could result in similar symptoms, was shown in the infant with jaundice described by Kamerbeek et al. [<xref rid="B140-biomolecules-14-00206" ref-type="bibr">140</xref>]. However, in the few studies available, no other possible genetic causes for the described symptoms were genetically excluded, e.g., by whole exome analysis. That humans can be rather robust toward reduced GSR activity is also exemplified by the high frequency of moderate GSR deficiency due to malnutrition, specifically due to the lack of riboflavin, which is a precursor of the GSR cofactor flavin adenine dinucleotide (FAD) in some populations [<xref rid="B141-biomolecules-14-00206" ref-type="bibr">141</xref>,<xref rid="B142-biomolecules-14-00206" ref-type="bibr">142</xref>]. </p>
          </sec>
          <sec>
            <title>Thioredoxin Reductase, TXNR</title>
            <p>Humans express three thioredoxin reductase isoforms: TXNRD1, TXNRD2, TXNRD3. <italic toggle="yes">Txnrd1</italic> and <italic toggle="yes">Txnrd2</italic> knockout were shown to be embryonically lethal in mice [<xref rid="B143-biomolecules-14-00206" ref-type="bibr">143</xref>]. <italic toggle="yes">Txnrd3</italic> knockout mice are viable and without discernible phenotype. However, male mice have impaired fertility, which points to a rather specific function of Txnrd3 in spermatogenesis [<xref rid="B144-biomolecules-14-00206" ref-type="bibr">144</xref>]. In humans, to our knowledge, no disease phenotype has been described for all three genes.</p>
          </sec>
        </sec>
        <sec id="sec3dot2dot4-biomolecules-14-00206">
          <title>3.2.4. NADPH&#x2014;The Key Coenzyme of the Anti-Oxidant Response</title>
          <p>Regeneration of reduced thiols from disulfides by reductases requires a constant supply of the universal redox coenzyme NADPH. Several cytosolic and mitochondrial enzymes convert NADP<sup>+</sup> into NADPH. </p>
          <sec>
            <title>The Oxidative Pentose Phosphate Pathway, oxPPP</title>
            <p>The most prominent enzyme in the category of NADPH production is the pentose phosphate pathway enzyme glucose 6-phosphate dehydrogenase (G6PD). G6PD is generally considered to be the main source of cytoplasmic NADPH [<xref rid="B145-biomolecules-14-00206" ref-type="bibr">145</xref>]. Complete G6PD knockout was shown to be embryonically lethal in mice [<xref rid="B146-biomolecules-14-00206" ref-type="bibr">146</xref>]. In humans, more than 200 pathogenic <italic toggle="yes">G6PD</italic> variants have been described. The most severe manifestations have residual enzyme activity of around 5% [<xref rid="B147-biomolecules-14-00206" ref-type="bibr">147</xref>]. With over 400 million cases worldwide, X-linked recessive G6PD deficiency (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) is the most common enzymopathy in humans, and the most common symptoms are neonatal jaundice and acute hemolytic anemia [<xref rid="B148-biomolecules-14-00206" ref-type="bibr">148</xref>]. Hemolysis is mainly triggered by external factors such as drugs, certain foods (e.g., fava beans), or infection [<xref rid="B149-biomolecules-14-00206" ref-type="bibr">149</xref>]. Otherwise, individuals with G6PD deficiency are mostly symptom-free [<xref rid="B148-biomolecules-14-00206" ref-type="bibr">148</xref>]. The high frequencies of G6PD alleles in populations that geographically overlap with the distribution of malaria-causing <italic toggle="yes">Plasmodium falciparum</italic> indicate at least partial protective effects of these alleles against the infectious disease [<xref rid="B147-biomolecules-14-00206" ref-type="bibr">147</xref>]. G6PD deficiency is an example of a redox disorder that only displays symptoms when the anti-oxidative capacity of the cell is overwhelmed due to acute oxidative stress and insufficient NADPH supplies. Otherwise, the residual activity of G6PD is sufficient to maintain health. Additionally, it was shown that, although G6PD is a major source of NADPH, it is dispensable for pentose production [<xref rid="B150-biomolecules-14-00206" ref-type="bibr">150</xref>]. </p>
            <p>The second NADPH-producing enzyme of the oxPPP is 6-phosphogluconate dehydrogenase (PGD). PGD deficiency (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) was found to cause transient hemolysis and well-compensated chronic nonspherocytic hemolytic anemia. Inheritance was described as autosomal dominant [<xref rid="B151-biomolecules-14-00206" ref-type="bibr">151</xref>]. However, the genotype-phenotype relationship is not unequivocally established and individuals who were found in population surveys who had PGD activity of less than 5% in RBC were completely healthy [<xref rid="B152-biomolecules-14-00206" ref-type="bibr">152</xref>].</p>
          </sec>
          <sec>
            <title>Malic Enzyme and Glutamate Dehydrogenase</title>
            <p>There are two NADPH-producing isoforms of malic enzyme (ME) in humans: cytosolic ME1 and mitochondrial ME3. ME1 and 3 catalyze the reversible decarboxylation of malate to pyruvate. In mice, knockout of <italic toggle="yes">Me1</italic> causes decreased body weight [<xref rid="B153-biomolecules-14-00206" ref-type="bibr">153</xref>,<xref rid="B154-biomolecules-14-00206" ref-type="bibr">154</xref>], and no specific phenotype was published for knockout of <italic toggle="yes">Me3</italic> to our knowledge. Neither of the two genes has been described as associated with monogenic disorders in humans. </p>
            <p>Glutamate dehydrogenase (GLUD) catalyzes the conversion of glutamate to &#x3B1;-ketoglutarate and ammonia while producing NADPH [<xref rid="B155-biomolecules-14-00206" ref-type="bibr">155</xref>]. There are two mitochondrial isoforms, GLUD1 and GLUD2. Only <italic toggle="yes">GLUD1</italic> has been described in association with a genetic phenotype&#x2014;autosomal dominant hyperinsulinism-hyperammonemia syndrome (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) [<xref rid="B156-biomolecules-14-00206" ref-type="bibr">156</xref>]. </p>
          </sec>
          <sec>
            <title>Isocitrate Dehydrogenase</title>
            <p>Humans possess two IDH isoforms that produce NADPH by converting isocitrate to &#x3B1;-ketoglutarate (&#x3B1;-KG): cytosolic IDH1 and mitochondrial IDH2. <italic toggle="yes">Idh1</italic> knockout is viable in mice, but the animals display greater susceptibility to oxidative stress [<xref rid="B157-biomolecules-14-00206" ref-type="bibr">157</xref>]. No monogenic disorder has been described for <italic toggle="yes">IDH1</italic> in humans, although pathogenic IDH1 variants are common in human neoplastic disorders [<xref rid="B158-biomolecules-14-00206" ref-type="bibr">158</xref>]. <italic toggle="yes">Idh2</italic> knockout mice show susceptibility to mitochondrial dysfunction, cardiac hypertrophy, and accelerated age-related hearing loss [<xref rid="B159-biomolecules-14-00206" ref-type="bibr">159</xref>,<xref rid="B160-biomolecules-14-00206" ref-type="bibr">160</xref>]. However, in humans, <italic toggle="yes">IDH2</italic> has been described as related to D-2-hydroxyglutaric aciduria 2 (D2HGA2, <xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>). Kranendijk et al. identified 15 unrelated patients with specific de novo heterozygous variants affecting codon R140 (NM_002168.2). D2HGA2 has a wide phenotypic spectrum from asymptomatic to severe neurological disorder with developmental delay, epilepsy, dysmorphic features, and cardiomyopathy. The phenotype was not described to be caused by elevated oxidative stress but by an increase in a promiscuous newly introduced enzymatic function that is of low activity in the wild type enzyme: the described variants reduce the enzyme&#x2019;s ability to convert isocitrate to &#x3B1;-KG but increase the conversion of &#x3B1;-KG into D-2-hydroxyglutarate [<xref rid="B158-biomolecules-14-00206" ref-type="bibr">158</xref>]. </p>
          </sec>
          <sec>
            <title>Folate Metabolism</title>
            <p>The importance and amount of NADPH derived from folate metabolism have been described in several publications in 2014 [<xref rid="B145-biomolecules-14-00206" ref-type="bibr">145</xref>,<xref rid="B161-biomolecules-14-00206" ref-type="bibr">161</xref>,<xref rid="B162-biomolecules-14-00206" ref-type="bibr">162</xref>]. In proliferating cells&#x2014;hence not in RBCs&#x2014;the NADPH production from folate metabolism almost equals that from the oxidative pentose phosphate pathway [<xref rid="B161-biomolecules-14-00206" ref-type="bibr">161</xref>]. </p>
            <p>The folate cycle gene methylenetetrahydrofolate dehydrogenase (MTHFD) converts 5,10-methylenetetrahydrofolate and NADP<sup>+</sup> into 5,10-methenyltetrahydrofolate and NADPH [<xref rid="B163-biomolecules-14-00206" ref-type="bibr">163</xref>]. Knockout of the genes <italic toggle="yes">Mthfd1</italic> or <italic toggle="yes">Mthfd2</italic> is embryonically lethal in mice [<xref rid="B164-biomolecules-14-00206" ref-type="bibr">164</xref>,<xref rid="B165-biomolecules-14-00206" ref-type="bibr">165</xref>]. No genetic disease has been described for the human mitochondrial isoform MTHFD2. However, autosomal recessive pathogenic <italic toggle="yes">MTHFD1</italic> variants cause the ultra-rare disorder &#x201C;combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia&#x201D; (<xref rid="biomolecules-14-00206-t001" ref-type="table">Table 1</xref>) [<xref rid="B166-biomolecules-14-00206" ref-type="bibr">166</xref>,<xref rid="B167-biomolecules-14-00206" ref-type="bibr">167</xref>]. Functional studies on patient fibroblasts revealed severely impaired methionine production but did not analyze for potential oxidative stress in these cells [<xref rid="B168-biomolecules-14-00206" ref-type="bibr">168</xref>]. </p>
            <p>The folate cycle enzyme formyltetrahydrofolate dehydrogenase, alternatively named aldehyde dehydrogenase 1 family member L (ALDH1L), produces tetrahydrofolate and CO<sub>2</sub> from 10-formyltetrahydrofolate under simultaneous NADPH production [<xref rid="B169-biomolecules-14-00206" ref-type="bibr">169</xref>]. There are two isoforms in humans: cytosolic ALDH1L1 and mitochondrial ALDH1L2 [<xref rid="B170-biomolecules-14-00206" ref-type="bibr">170</xref>]. Knockout of <italic toggle="yes">Aldh1l1</italic> in mice resulted in no obvious phenotype [<xref rid="B171-biomolecules-14-00206" ref-type="bibr">171</xref>], and no inherited monogenic disorder has been described in humans. Interestingly, for <italic toggle="yes">ALDH1L2</italic>, one patient was described with a neuro-ichthyotic syndrome characterized by ichthyosis, thick fingers and toes, dysmorphic features, and developmental delay. Two <italic toggle="yes">ALDH1L2</italic> variants were detected in the index patient in compound heterozygosity, which indicates autosomal recessive inheritance. Functional analyses in the patient&#x2019;s fibroblasts confirmed impaired mitochondrial metabolism with impact on &#x3B2;-oxidation of fatty acids [<xref rid="B172-biomolecules-14-00206" ref-type="bibr">172</xref>]. Knockout of <italic toggle="yes">Aldh1l2</italic> resulted in normally appearing mice. However, in-depth physiological analysis confirmed, e.g., reduced NADPH, abnormal lipid metabolism, showed drastically reduced GSH levels, and increased oxidative stress which impacted &#x3B2;-oxidation of fatty acids [<xref rid="B173-biomolecules-14-00206" ref-type="bibr">173</xref>]. Nevertheless, further patients from different families would support an unequivocal genotype-phenotype association. </p>
            <table-wrap position="anchor" id="biomolecules-14-00206-t001">
              <object-id pub-id-type="pii">biomolecules-14-00206-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Summary of discussed genes and phenotypes. AR, autosomal recessive, AD, autosomal dominant, XLR, X-linked recessive, OMIM<bold><sup>&#xAE;</sup></bold>, Online Mendelian Inheritance in Man database.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene (OMIM<sup>&#xAE;</sup> no.)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Monogenic Disease (OMIM<sup>&#xAE;</sup>no<sup>.</sup>)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inheritance</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Described by</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">ROS production</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hemoglobin beta-locus</td>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">HBB</italic> (141900)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sickle cell disease (603903)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-biomolecules-14-00206" ref-type="bibr">39</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methemoglobinemia, beta type (617971)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-biomolecules-14-00206" ref-type="bibr">38</xref>]</td>
                  </tr>
                  <tr>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cytochrome b(-245), beta subunit, p91-phox</td>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">CYBB</italic> (300481)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic granulomatous disease (306400)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XLR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-biomolecules-14-00206" ref-type="bibr">53</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunodeficiency 34, mycobacteriosis (300645)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XLR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-biomolecules-14-00206" ref-type="bibr">54</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytochrome b(-245), alpha subunit, p22-phox</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">CYBA</italic> (608508)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic granulomatous disease 4 (233690)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-biomolecules-14-00206" ref-type="bibr">55</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutrophil cytosolic factor-1, p47-phox</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NCF1</italic> (608512)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic granulomatous disease 1 (233700)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-biomolecules-14-00206" ref-type="bibr">56</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutrophil cytosolic factor-2, p67-phox</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NCF2</italic> (608515)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic granulomatous disease 2 (233710)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-biomolecules-14-00206" ref-type="bibr">57</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutrophil cytosolic factor-4, p40-phox</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NCF4</italic> (601488)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic granulomatous disease 3 (613960)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-biomolecules-14-00206" ref-type="bibr">58</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myeloperoxidase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">MPO</italic> (606989)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myeloperoxidase deficiency (254600)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-biomolecules-14-00206" ref-type="bibr">70</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xanthine dehydrogenase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">XDH</italic> (607633)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xanthinuria, type I (278300)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-biomolecules-14-00206" ref-type="bibr">75</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitric oxide synthase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NOS1</italic> (163731)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitric oxide synthase 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NOS2</italic> (163730)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitric oxide synthase 3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">NOS3</italic> (163729)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">enzymatic ROS clearance</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">superoxide dismutase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">SOD1</italic> (147450)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amyotrophic lateral sclerosis 1 (105400)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD, AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-biomolecules-14-00206" ref-type="bibr">93</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spastic tetraplegia and axial hypotonia, progressive (618598)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-biomolecules-14-00206" ref-type="bibr">99</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">superoxide dismutase 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">SOD2</italic> (147460)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">superoxide dismutase 3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">SOD3</italic> (185490)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">catalase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">CAT</italic> (115500)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acatalasemia (614097)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-biomolecules-14-00206" ref-type="bibr">102</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutathione peroxidase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GPX1</italic> (138320)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemolytic anemia due to glutathione peroxidase deficiency (614164)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B108-biomolecules-14-00206" ref-type="bibr">108</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutathione peroxidase 4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GPX4</italic> (138322)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spondylometaphyseal dysplasia, Sedaghatian type (250220)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-biomolecules-14-00206" ref-type="bibr">110</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutathione peroxidase 2, 3, 5-8</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GPX2</italic> (138319) <italic toggle="yes">GPX3</italic> (138321) <italic toggle="yes">GPX5</italic> (603435) <italic toggle="yes">GPX6</italic> (607913) <italic toggle="yes">GPX7</italic> (615784) <italic toggle="yes">GPX8</italic> (617172)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">peroxiredoxin 3</td>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">PRDX3</italic> (604769)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corneal dystrophy, punctiform, and polychromatic pre-Descemet (619871)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-biomolecules-14-00206" ref-type="bibr">120</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spinocerebellar ataxia, autosomal recessive 32 (619862)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B116-biomolecules-14-00206" ref-type="bibr">116</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">peroxiredoxin 1, 2, 4, 5, 6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">PRDX1</italic> (176763) <italic toggle="yes">PRDX2</italic> (600538) <italic toggle="yes">PRDX4</italic> (300927) <italic toggle="yes">PRDX5</italic> (606583) <italic toggle="yes">PRDX6</italic> (602316)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">thiols and thiol production</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gamma-glutamylcysteine synthetase, catalytic subunit</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GCLC</italic> (606857)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (230450)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-biomolecules-14-00206" ref-type="bibr">124</xref>]</td>
                  </tr>
                  <tr>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">glutathione synthetase</td>
                    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">GSS</italic> (601002)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glutathione synthetase deficiency (266130)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-biomolecules-14-00206" ref-type="bibr">127</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemolytic anemia due to glutathione synthetase deficiency (231900)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-biomolecules-14-00206" ref-type="bibr">126</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">thioredoxin 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">TXN2</italic> (609063)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combined oxidative phosphorylation deficiency 29 (616811)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-biomolecules-14-00206" ref-type="bibr">135</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">thioredoxin</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">TXN</italic> (187700)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">thiol recycling</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutathione reductase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GSR</italic> (138300)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemolytic anemia due to glutathione reductase deficiency (618660)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-biomolecules-14-00206" ref-type="bibr">138</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">thioredoxin reductase 1, 2, 3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">TXNRD1</italic> (601112) <italic toggle="yes">TXNRD2</italic> (606448) <italic toggle="yes">TXNRD3</italic> (606235)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">NADPH production</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glucose 6P-dehydrogenase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">G6PD</italic> (305900)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemolytic anemia, G6PD deficient (favism) (611162)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B147-biomolecules-14-00206" ref-type="bibr">147</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-phosphogluconate dehydrogenase</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">PGD</italic> (172200)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphogluconate dehydrogenase deficiency (619199)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-biomolecules-14-00206" ref-type="bibr">151</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">malic enzyme 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ME1</italic> (154250)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">malic enzyme 3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ME3</italic> (604626)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutamate dehydrogenase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GLUD1</italic> (138130)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hyperinsulinism-hyperammonemia syndrome (606762)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B156-biomolecules-14-00206" ref-type="bibr">156</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutamate dehydrogenase 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">GLUD2</italic> (300144)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">isocitrate dehydrogenase 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">IDH2</italic> (147650)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-2-hydroxyglutaric aciduria 2 (613657)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B158-biomolecules-14-00206" ref-type="bibr">158</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">isocitrate dehydrogenase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">IDH1</italic> (147700)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methylenetetrahydrofolate dehydrogenase 1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">MTHFD1</italic> (172460)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (617780)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-biomolecules-14-00206" ref-type="bibr">166</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methylenetetrahydrofolate dehydrogenase 2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">MTHFD2</italic> (604887)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-formyltetrahydrofolate dehydrogenase (mitochondrial)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ALDH1L2</italic> (613584)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">neuro-ichthyotic syndrome?</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B172-biomolecules-14-00206" ref-type="bibr">172</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-formyltetrahydrofolate dehydrogenase (cytosolic)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">ALDH1L1</italic> (600249)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
        </sec>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec4-biomolecules-14-00206">
      <title>4. Conclusions</title>
      <p>In this review, we explored monogenic diseases related to genes associated with endogenous ROS production and anti-oxidative defense systems, and we described the most common as well as some of the rarest genetic disorders. Of note, this article aimed at providing an overview of the most significant genes involved in redox metabolism and its regulation&#x2014;while there are numerous further metabolic pathway enzymes located upstream of the described genes that could also have a potential impact on the discussed functions. Herein, attention was drawn to extremely rare genetic conditions. For some disorders, only few patients have been described despite the recent surge in sample throughput by more and more affordable sequencing technologies, as well as fast progress in other analytical technologies, including metabolomics and proteomics. Since a vast number of samples are processed by diagnostic companies and not research active clinics or institutes, comprehensive re-analysis of proprietary databases might identify further patients that would back up weak genotype-phenotype links. This would not only improve diagnostics of rare diseases but also provide valuable information for basic biochemical research. </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We would like to thank Michael Breitenbach for his invaluable support, extensive knowledge, and mentorship throughout the years. Breitenbach&#x2019;s guidance has played a pivotal role in shaping the direction of our work, and his unwavering commitment to advancing scientific understanding has been a constant source of inspiration. We would also like to thank Julia Muenzner and Johannes Hartl for critical reading of this manuscript.</p>
    </ack>
    <fn-group>
      <fn>
        <p><bold>Disclaimer/Publisher&#x2019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p>
      </fn>
    </fn-group>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-biomolecules-14-00206">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fenton</surname><given-names>H.J.H.</given-names></name>
</person-group>
          <article-title>LXXIII.&#x2014;Oxidation of Tartaric Acid in Presence of Iron</article-title>
          <source>J. Chem. Soc. Trans.</source>
          <year>1894</year>
          <volume>65</volume>
          <fpage>899</fpage>
          <lpage>910</lpage>
          <pub-id pub-id-type="doi">10.1039/CT8946500899</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-biomolecules-14-00206">
        <label>2.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tavassolifar</surname><given-names>M.J.</given-names></name>
<name><surname>Vodjgani</surname><given-names>M.</given-names></name>
<name><surname>Salehi</surname><given-names>Z.</given-names></name>
<name><surname>Izad</surname><given-names>M.</given-names></name>
</person-group><article-title>The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis</article-title><source>Autoimmune Dis.</source><year>2020</year><volume>2020</volume><fpage>5793817</fpage><pub-id pub-id-type="doi">10.1155/2020/5793817</pub-id><pub-id pub-id-type="pmid">32789026</pub-id>
</element-citation>
      </ref>
      <ref id="B3-biomolecules-14-00206">
        <label>3.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Birben</surname><given-names>E.</given-names></name>
<name><surname>Sahiner</surname><given-names>U.M.</given-names></name>
<name><surname>Sackesen</surname><given-names>C.</given-names></name>
<name><surname>Erzurum</surname><given-names>S.</given-names></name>
<name><surname>Kalayci</surname><given-names>O.</given-names></name>
</person-group><article-title>Oxidative Stress and Antioxidant Defense</article-title><source>World Allergy Organ. J.</source><year>2012</year><volume>5</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1097/WOX.0b013e3182439613</pub-id><pub-id pub-id-type="pmid">23268465</pub-id>
</element-citation>
      </ref>
      <ref id="B4-biomolecules-14-00206">
        <label>4.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Devasagayam</surname><given-names>T.P.A.</given-names></name>
<name><surname>Tilak</surname><given-names>J.C.</given-names></name>
<name><surname>Boloor</surname><given-names>K.K.</given-names></name>
<name><surname>Sane</surname><given-names>K.S.</given-names></name>
<name><surname>Ghaskadbi</surname><given-names>S.S.</given-names></name>
<name><surname>Lele</surname><given-names>R.D.</given-names></name>
</person-group><article-title>Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects</article-title><source>J. Assoc. Physicians India</source><year>2004</year><volume>52</volume><fpage>794</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">15909857</pub-id>
</element-citation>
      </ref>
      <ref id="B5-biomolecules-14-00206">
        <label>5.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hensley</surname><given-names>K.</given-names></name>
<name><surname>Robinson</surname><given-names>K.A.</given-names></name>
<name><surname>Gabbita</surname><given-names>S.P.</given-names></name>
<name><surname>Salsman</surname><given-names>S.</given-names></name>
<name><surname>Floyd</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Reactive Oxygen Species, Cell Signaling, and Cell Injury</article-title><source>Free Radic. Biol. Med.</source><year>2000</year><volume>28</volume><fpage>1456</fpage><lpage>1462</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(00)00252-5</pub-id><pub-id pub-id-type="pmid">10927169</pub-id>
</element-citation>
      </ref>
      <ref id="B6-biomolecules-14-00206">
        <label>6.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>D&#x2019;Autr&#xE9;aux</surname><given-names>B.</given-names></name>
<name><surname>Toledano</surname><given-names>M.B.</given-names></name>
</person-group><article-title>ROS as Signalling Molecules: Mechanisms That Generate Specificity in ROS Homeostasis</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2007</year><volume>8</volume><fpage>813</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1038/nrm2256</pub-id><pub-id pub-id-type="pmid">17848967</pub-id>
</element-citation>
      </ref>
      <ref id="B7-biomolecules-14-00206">
        <label>7.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Bazhin</surname><given-names>A.V.</given-names></name>
<name><surname>Werner</surname><given-names>J.</given-names></name>
<name><surname>Karakhanova</surname><given-names>S.</given-names></name>
</person-group><article-title>Reactive Oxygen Species in the Immune System</article-title><source>Int. Rev. Immunol.</source><year>2013</year><volume>32</volume><fpage>249</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.3109/08830185.2012.755176</pub-id><pub-id pub-id-type="pmid">23617726</pub-id>
</element-citation>
      </ref>
      <ref id="B8-biomolecules-14-00206">
        <label>8.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sies</surname><given-names>H.</given-names></name>
<name><surname>Berndt</surname><given-names>C.</given-names></name>
<name><surname>Jones</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Oxidative Stress</article-title><source>Annu. Rev. Biochem.</source><year>2017</year><volume>86</volume><fpage>715</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045037</pub-id><pub-id pub-id-type="pmid">28441057</pub-id>
</element-citation>
      </ref>
      <ref id="B9-biomolecules-14-00206">
        <label>9.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Favier</surname><given-names>A.</given-names></name>
</person-group><article-title>Oxidative stress in human diseases</article-title><source>Ann. Pharm. Fr.</source><year>2006</year><volume>64</volume><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/S0003-4509(06)75334-2</pub-id><pub-id pub-id-type="pmid">17119468</pub-id>
</element-citation>
      </ref>
      <ref id="B10-biomolecules-14-00206">
        <label>10.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Espin&#xF3;s</surname><given-names>C.</given-names></name>
<name><surname>Galindo</surname><given-names>M.I.</given-names></name>
<name><surname>Garc&#xED;a-Gimeno</surname><given-names>M.A.</given-names></name>
<name><surname>Ib&#xE1;&#xF1;ez-Cabellos</surname><given-names>J.S.</given-names></name>
<name><surname>Mart&#xED;nez-Rubio</surname><given-names>D.</given-names></name>
<name><surname>Mill&#xE1;n</surname><given-names>J.M.</given-names></name>
<name><surname>Rodrigo</surname><given-names>R.</given-names></name>
<name><surname>Sanz</surname><given-names>P.</given-names></name>
<name><surname>Seco-Cervera</surname><given-names>M.</given-names></name>
<name><surname>Sevilla</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>313</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9040313</pub-id><pub-id pub-id-type="pmid">32326494</pub-id>
</element-citation>
      </ref>
      <ref id="B11-biomolecules-14-00206">
        <label>11.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matschke</surname><given-names>V.</given-names></name>
<name><surname>Theiss</surname><given-names>C.</given-names></name>
<name><surname>Matschke</surname><given-names>J.</given-names></name>
</person-group><article-title>Oxidative Stress: The Lowest Common Denominator of Multiple Diseases</article-title><source>Neural Regen. Res.</source><year>2019</year><volume>14</volume><fpage>238</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.244780</pub-id><pub-id pub-id-type="pmid">30531003</pub-id>
</element-citation>
      </ref>
      <ref id="B12-biomolecules-14-00206">
        <label>12.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jasoliya</surname><given-names>M.J.</given-names></name>
<name><surname>McMackin</surname><given-names>M.Z.</given-names></name>
<name><surname>Henderson</surname><given-names>C.K.</given-names></name>
<name><surname>Perlman</surname><given-names>S.L.</given-names></name>
<name><surname>Cortopassi</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Frataxin Deficiency Impairs Mitochondrial Biogenesis in Cells, Mice and Humans</article-title><source>Hum. Mol. Genet.</source><year>2017</year><volume>26</volume><fpage>2627</fpage><lpage>2633</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx141</pub-id><pub-id pub-id-type="pmid">28444186</pub-id>
</element-citation>
      </ref>
      <ref id="B13-biomolecules-14-00206">
        <label>13.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vaubel</surname><given-names>R.A.</given-names></name>
<name><surname>Isaya</surname><given-names>G.</given-names></name>
</person-group><article-title>Iron-Sulfur Cluster Synthesis, Iron Homeostasis and Oxidative Stress in Friedreich Ataxia</article-title><source>Mol. Cell. Neurosci.</source><year>2013</year><volume>55</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2012.08.003</pub-id><pub-id pub-id-type="pmid">22917739</pub-id>
</element-citation>
      </ref>
      <ref id="B14-biomolecules-14-00206">
        <label>14.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chantrel-Groussard</surname><given-names>K.</given-names></name>
<name><surname>Geromel</surname><given-names>V.</given-names></name>
<name><surname>Puccio</surname><given-names>H.</given-names></name>
<name><surname>Koenig</surname><given-names>M.</given-names></name>
<name><surname>Munnich</surname><given-names>A.</given-names></name>
<name><surname>R&#xF6;tig</surname><given-names>A.</given-names></name>
<name><surname>Rustin</surname><given-names>P.</given-names></name>
</person-group><article-title>Disabled Early Recruitment of Antioxidant Defenses in Friedreich&#x2019;s Ataxia</article-title><source>Hum. Mol. Genet.</source><year>2001</year><volume>10</volume><fpage>2061</fpage><lpage>2067</lpage><pub-id pub-id-type="doi">10.1093/hmg/10.19.2061</pub-id><pub-id pub-id-type="pmid">11590123</pub-id>
</element-citation>
      </ref>
      <ref id="B15-biomolecules-14-00206">
        <label>15.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rom&#xE1;-Mateo</surname><given-names>C.</given-names></name>
<name><surname>Garc&#xED;a-Gim&#xE9;nez</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues</article-title><source>Antioxidants</source><year>2021</year><volume>10</volume><elocation-id>617</elocation-id><pub-id pub-id-type="doi">10.3390/antiox10040617</pub-id><pub-id pub-id-type="pmid">33923815</pub-id>
</element-citation>
      </ref>
      <ref id="B16-biomolecules-14-00206">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dom&#xE8;nech</surname><given-names>B.E.</given-names></name>
<name><surname>Marfany</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>The Relevance of Oxidative Stress in the Pathogenesis and Therapy of Retinal Dystrophies</article-title>
          <source>Antioxid. Redox Signal.</source>
          <year>2020</year>
          <volume>9</volume>
          <elocation-id>347</elocation-id>
          <pub-id pub-id-type="doi">10.3390/antiox9040347</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-biomolecules-14-00206">
        <label>17.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maciejczyk</surname><given-names>M.</given-names></name>
<name><surname>Mikoluc</surname><given-names>B.</given-names></name>
<name><surname>Pietrucha</surname><given-names>B.</given-names></name>
<name><surname>Heropolitanska-Pliszka</surname><given-names>E.</given-names></name>
<name><surname>Pac</surname><given-names>M.</given-names></name>
<name><surname>Motkowski</surname><given-names>R.</given-names></name>
<name><surname>Car</surname><given-names>H.</given-names></name>
</person-group><article-title>Oxidative Stress, Mitochondrial Abnormalities and Antioxidant Defense in Ataxia-Telangiectasia, Bloom Syndrome and Nijmegen Breakage Syndrome</article-title><source>Redox Biol.</source><year>2017</year><volume>11</volume><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2016.12.030</pub-id><pub-id pub-id-type="pmid">28063379</pub-id>
</element-citation>
      </ref>
      <ref id="B18-biomolecules-14-00206">
        <label>18.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muller</surname><given-names>F.</given-names></name>
</person-group><article-title>The Nature and Mechanism of Superoxide Production by the Electron Transport Chain: Its Relevance to Aging</article-title><source>J. Am. Aging Assoc.</source><year>2000</year><volume>23</volume><fpage>227</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1007/s11357-000-0022-9</pub-id><pub-id pub-id-type="pmid">23604868</pub-id>
</element-citation>
      </ref>
      <ref id="B19-biomolecules-14-00206">
        <label>19.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Turrens</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Mitochondrial Formation of Reactive Oxygen Species</article-title><source>J. Physiol.</source><year>2003</year><volume>552</volume><fpage>335</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.049478</pub-id><pub-id pub-id-type="pmid">14561818</pub-id>
</element-citation>
      </ref>
      <ref id="B20-biomolecules-14-00206">
        <label>20.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hadrava Vanova</surname><given-names>K.</given-names></name>
<name><surname>Kraus</surname><given-names>M.</given-names></name>
<name><surname>Neuzil</surname><given-names>J.</given-names></name>
<name><surname>Rohlena</surname><given-names>J.</given-names></name>
</person-group><article-title>Mitochondrial Complex II and Reactive Oxygen Species in Disease and Therapy</article-title><source>Redox Rep.</source><year>2020</year><volume>25</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1080/13510002.2020.1752002</pub-id><pub-id pub-id-type="pmid">32290794</pub-id>
</element-citation>
      </ref>
      <ref id="B21-biomolecules-14-00206">
        <label>21.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>L.K.</given-names></name>
<name><surname>Fang</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Vartak</surname><given-names>R.</given-names></name>
<name><surname>Deng</surname><given-names>J.</given-names></name>
<name><surname>Bai</surname><given-names>Y.</given-names></name>
</person-group><article-title>Mitochondrial Respiratory Complex I Dysfunction Promotes Tumorigenesis through ROS Alteration and AKT Activation</article-title><source>Hum. Mol. Genet.</source><year>2011</year><volume>20</volume><fpage>4605</fpage><lpage>4616</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr395</pub-id><pub-id pub-id-type="pmid">21890492</pub-id>
</element-citation>
      </ref>
      <ref id="B22-biomolecules-14-00206">
        <label>22.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fullerton</surname><given-names>M.</given-names></name>
<name><surname>McFarland</surname><given-names>R.</given-names></name>
<name><surname>Taylor</surname><given-names>R.W.</given-names></name>
<name><surname>Alston</surname><given-names>C.L.</given-names></name>
</person-group><article-title>The Genetic Basis of Isolated Mitochondrial Complex II Deficiency</article-title><source>Mol. Genet. Metab.</source><year>2020</year><volume>131</volume><fpage>53</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2020.09.009</pub-id><pub-id pub-id-type="pmid">33162331</pub-id>
</element-citation>
      </ref>
      <ref id="B23-biomolecules-14-00206">
        <label>23.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iwata</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>J.W.</given-names></name>
<name><surname>Okada</surname><given-names>K.</given-names></name>
<name><surname>Lee</surname><given-names>J.K.</given-names></name>
<name><surname>Iwata</surname><given-names>M.</given-names></name>
<name><surname>Rasmussen</surname><given-names>B.</given-names></name>
<name><surname>Link</surname><given-names>T.A.</given-names></name>
<name><surname>Ramaswamy</surname><given-names>S.</given-names></name>
<name><surname>Jap</surname><given-names>B.K.</given-names></name>
</person-group><article-title>Complete Structure of the 11-Subunit Bovine Mitochondrial Cytochrome bc1 Complex</article-title><source>Science</source><year>1998</year><volume>281</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1126/science.281.5373.64</pub-id><pub-id pub-id-type="pmid">9651245</pub-id>
</element-citation>
      </ref>
      <ref id="B24-biomolecules-14-00206">
        <label>24.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hernansanz-Agust&#xED;n</surname><given-names>P.</given-names></name>
<name><surname>Enr&#xED;quez</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Generation of Reactive Oxygen Species by Mitochondria</article-title><source>Antioxidants</source><year>2021</year><volume>10</volume><elocation-id>415</elocation-id><pub-id pub-id-type="doi">10.3390/antiox10030415</pub-id><pub-id pub-id-type="pmid">33803273</pub-id>
</element-citation>
      </ref>
      <ref id="B25-biomolecules-14-00206">
        <label>25.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maranzana</surname><given-names>E.</given-names></name>
<name><surname>Barbero</surname><given-names>G.</given-names></name>
<name><surname>Falasca</surname><given-names>A.I.</given-names></name>
<name><surname>Lenaz</surname><given-names>G.</given-names></name>
<name><surname>Genova</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Mitochondrial Respiratory Supercomplex Association Limits Production of Reactive Oxygen Species from Complex I</article-title><source>Antioxid. Redox Signal.</source><year>2013</year><volume>19</volume><fpage>1469</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.4845</pub-id><pub-id pub-id-type="pmid">23581604</pub-id>
</element-citation>
      </ref>
      <ref id="B26-biomolecules-14-00206">
        <label>26.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez-Fabuel</surname><given-names>I.</given-names></name>
<name><surname>Le Douce</surname><given-names>J.</given-names></name>
<name><surname>Logan</surname><given-names>A.</given-names></name>
<name><surname>James</surname><given-names>A.M.</given-names></name>
<name><surname>Bonvento</surname><given-names>G.</given-names></name>
<name><surname>Murphy</surname><given-names>M.P.</given-names></name>
<name><surname>Almeida</surname><given-names>A.</given-names></name>
<name><surname>Bola&#xF1;os</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Complex I Assembly into Supercomplexes Determines Differential Mitochondrial ROS Production in Neurons and Astrocytes</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>13063</fpage><lpage>13068</lpage><pub-id pub-id-type="doi">10.1073/pnas.1613701113</pub-id><pub-id pub-id-type="pmid">27799543</pub-id>
</element-citation>
      </ref>
      <ref id="B27-biomolecules-14-00206">
        <label>27.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jain</surname><given-names>I.H.</given-names></name>
<name><surname>Zazzeron</surname><given-names>L.</given-names></name>
<name><surname>Goldberger</surname><given-names>O.</given-names></name>
<name><surname>Marutani</surname><given-names>E.</given-names></name>
<name><surname>Wojtkiewicz</surname><given-names>G.R.</given-names></name>
<name><surname>Ast</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Schleifer</surname><given-names>G.</given-names></name>
<name><surname>Stepanova</surname><given-names>A.</given-names></name>
<name><surname>Brepoels</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Leigh Syndrome Mouse Model Can Be Rescued by Interventions That Normalize Brain Hyperoxia, but Not HIF Activation</article-title><source>Cell Metab.</source><year>2019</year><volume>30</volume><fpage>824</fpage><lpage>832.e3</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.07.006</pub-id><pub-id pub-id-type="pmid">31402314</pub-id>
</element-citation>
      </ref>
      <ref id="B28-biomolecules-14-00206">
        <label>28.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perier</surname><given-names>C.</given-names></name>
<name><surname>Tieu</surname><given-names>K.</given-names></name>
<name><surname>Gu&#xE9;gan</surname><given-names>C.</given-names></name>
<name><surname>Caspersen</surname><given-names>C.</given-names></name>
<name><surname>Jackson-Lewis</surname><given-names>V.</given-names></name>
<name><surname>Carelli</surname><given-names>V.</given-names></name>
<name><surname>Martinuzzi</surname><given-names>A.</given-names></name>
<name><surname>Hirano</surname><given-names>M.</given-names></name>
<name><surname>Przedborski</surname><given-names>S.</given-names></name>
<name><surname>Vila</surname><given-names>M.</given-names></name>
</person-group><article-title>Complex I Deficiency Primes Bax-Dependent Neuronal Apoptosis through Mitochondrial Oxidative Damage</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>19126</fpage><lpage>19131</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508215102</pub-id><pub-id pub-id-type="pmid">16365298</pub-id>
</element-citation>
      </ref>
      <ref id="B29-biomolecules-14-00206">
        <label>29.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tretter</surname><given-names>L.</given-names></name>
<name><surname>Sipos</surname><given-names>I.</given-names></name>
<name><surname>Adam-Vizi</surname><given-names>V.</given-names></name>
</person-group><article-title>Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson&#x2019;s Disease</article-title><source>Neurochem. Res.</source><year>2004</year><volume>29</volume><fpage>569</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1023/B:NERE.0000014827.94562.4b</pub-id><pub-id pub-id-type="pmid">15038604</pub-id>
</element-citation>
      </ref>
      <ref id="B30-biomolecules-14-00206">
        <label>30.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Fiskum</surname><given-names>G.</given-names></name>
<name><surname>Schubert</surname><given-names>D.</given-names></name>
</person-group><article-title>Generation of Reactive Oxygen Species by the Mitochondrial Electron Transport Chain</article-title><source>J. Neurochem.</source><year>2002</year><volume>80</volume><fpage>780</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1046/j.0022-3042.2002.00744.x</pub-id><pub-id pub-id-type="pmid">11948241</pub-id>
</element-citation>
      </ref>
      <ref id="B31-biomolecules-14-00206">
        <label>31.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lake</surname><given-names>N.J.</given-names></name>
<name><surname>Compton</surname><given-names>A.G.</given-names></name>
<name><surname>Rahman</surname><given-names>S.</given-names></name>
<name><surname>Thorburn</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Leigh Syndrome: One Disorder, More than 75 Monogenic Causes</article-title><source>Ann. Neurol.</source><year>2016</year><volume>79</volume><fpage>190</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1002/ana.24551</pub-id><pub-id pub-id-type="pmid">26506407</pub-id>
</element-citation>
      </ref>
      <ref id="B32-biomolecules-14-00206">
        <label>32.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Riordan-Eva</surname><given-names>P.</given-names></name>
<name><surname>Harding</surname><given-names>A.E.</given-names></name>
</person-group><article-title>Leber&#x2019;s Hereditary Optic Neuropathy: The Clinical Relevance of Different Mitochondrial DNA Mutations</article-title><source>J. Med. Genet.</source><year>1995</year><volume>32</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1136/jmg.32.2.81</pub-id><pub-id pub-id-type="pmid">7760326</pub-id>
</element-citation>
      </ref>
      <ref id="B33-biomolecules-14-00206">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Di Monte</surname><given-names>D.A.</given-names></name>
</person-group>
          <article-title>Mitochondrial DNA and Parkinson&#x2019;s Disease</article-title>
          <source>Neurology</source>
          <year>1991</year>
          <volume>41</volume>
          <fpage>38</fpage>
          <lpage>43</lpage>
          <page-range>38&#x2013;42; discussion 42&#x2013;43</page-range>
          <pub-id pub-id-type="doi">10.1212/WNL.41.5_Suppl_2.38</pub-id>
        </element-citation>
      </ref>
      <ref id="B34-biomolecules-14-00206">
        <label>34.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ikebe</surname><given-names>S.</given-names></name>
<name><surname>Tanaka</surname><given-names>M.</given-names></name>
<name><surname>Ozawa</surname><given-names>T.</given-names></name>
</person-group><article-title>Point Mutations of Mitochondrial Genome in Parkinson&#x2019;s Disease</article-title><source>Brain Res. Mol. Brain Res.</source><year>1995</year><volume>28</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/0169-328X(94)00209-W</pub-id><pub-id pub-id-type="pmid">7723627</pub-id>
</element-citation>
      </ref>
      <ref id="B35-biomolecules-14-00206">
        <label>35.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tucker</surname><given-names>E.J.</given-names></name>
<name><surname>Compton</surname><given-names>A.G.</given-names></name>
<name><surname>Calvo</surname><given-names>S.E.</given-names></name>
<name><surname>Thorburn</surname><given-names>D.R.</given-names></name>
</person-group><article-title>The Molecular Basis of Human Complex I Deficiency</article-title><source>IUBMB Life</source><year>2011</year><volume>63</volume><fpage>669</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1002/iub.495</pub-id><pub-id pub-id-type="pmid">21766414</pub-id>
</element-citation>
      </ref>
      <ref id="B36-biomolecules-14-00206">
        <label>36.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Misra</surname><given-names>H.P.</given-names></name>
<name><surname>Fridovich</surname><given-names>I.</given-names></name>
</person-group><article-title>The Generation of Superoxide Radical during the Autoxidation of Hemoglobin</article-title><source>J. Biol. Chem.</source><year>1972</year><volume>247</volume><fpage>6960</fpage><lpage>6962</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)44679-6</pub-id><pub-id pub-id-type="pmid">4673289</pub-id>
</element-citation>
      </ref>
      <ref id="B37-biomolecules-14-00206">
        <label>37.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Winterbourn</surname><given-names>C.C.</given-names></name>
</person-group>
          <article-title>Oxidative Reactions of Hemoglobin</article-title>
          <source>Methods in Enzymology</source>
          <publisher-name>Academic Press</publisher-name>
          <publisher-loc>Cambridge, MA, USA</publisher-loc>
          <year>1990</year>
          <volume>Volume 186</volume>
          <fpage>265</fpage>
          <lpage>272</lpage>
        </element-citation>
      </ref>
      <ref id="B38-biomolecules-14-00206">
        <label>38.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schnedl</surname><given-names>W.J.</given-names></name>
<name><surname>Queissner</surname><given-names>R.</given-names></name>
<name><surname>Schenk</surname><given-names>M.</given-names></name>
<name><surname>Enko</surname><given-names>D.</given-names></name>
<name><surname>Mangge</surname><given-names>H.</given-names></name>
</person-group><article-title>Hereditary Methemoglobinemia Caused by Hb M-Hyde Park (Hb M-Akita) (<italic toggle="yes">HBB</italic>:c.277C &gt; T; p.His93Tyr)</article-title><source>Wien. Klin. Wochenschr.</source><year>2019</year><volume>131</volume><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1007/s00508-019-1525-2</pub-id><pub-id pub-id-type="pmid">31267164</pub-id>
</element-citation>
      </ref>
      <ref id="B39-biomolecules-14-00206">
        <label>39.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mears</surname><given-names>J.G.</given-names></name>
<name><surname>Lachman</surname><given-names>H.M.</given-names></name>
<name><surname>Cabannes</surname><given-names>R.</given-names></name>
<name><surname>Amegnizin</surname><given-names>K.P.</given-names></name>
<name><surname>Labie</surname><given-names>D.</given-names></name>
<name><surname>Nagel</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Sickle Gene. Its Origin and Diffusion from West Africa</article-title><source>J. Clin. Investig.</source><year>1981</year><volume>68</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1172/JCI110294</pub-id><pub-id pub-id-type="pmid">6268660</pub-id>
</element-citation>
      </ref>
      <ref id="B40-biomolecules-14-00206">
        <label>40.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rees</surname><given-names>D.C.</given-names></name>
<name><surname>Williams</surname><given-names>T.N.</given-names></name>
<name><surname>Gladwin</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Sickle-Cell Disease</article-title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>2018</fpage><lpage>2031</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61029-X</pub-id><pub-id pub-id-type="pmid">21131035</pub-id>
</element-citation>
      </ref>
      <ref id="B41-biomolecules-14-00206">
        <label>41.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hebbel</surname><given-names>R.P.</given-names></name>
<name><surname>Morgan</surname><given-names>W.T.</given-names></name>
<name><surname>Eaton</surname><given-names>J.W.</given-names></name>
<name><surname>Hedlund</surname><given-names>B.E.</given-names></name>
</person-group><article-title>Accelerated Autoxidation and Heme Loss due to Instability of Sickle Hemoglobin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1988</year><volume>85</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.1.237</pub-id><pub-id pub-id-type="pmid">3422420</pub-id>
</element-citation>
      </ref>
      <ref id="B42-biomolecules-14-00206">
        <label>42.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hebbel</surname><given-names>R.P.</given-names></name>
<name><surname>Ney</surname><given-names>P.A.</given-names></name>
<name><surname>Foker</surname><given-names>W.</given-names></name>
</person-group><article-title>Autoxidation, Dehydration, and Adhesivity May Be Related Abnormalities of Sickle Erythrocytes</article-title><source>Am. J. Physiol.</source><year>1989</year><volume>256</volume><fpage>C579</fpage><lpage>C583</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1989.256.3.C579</pub-id><pub-id pub-id-type="pmid">2923193</pub-id>
</element-citation>
      </ref>
      <ref id="B43-biomolecules-14-00206">
        <label>43.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Zennadi</surname><given-names>R.</given-names></name>
</person-group><article-title>The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications</article-title><source>Antioxidants</source><year>2021</year><volume>10</volume><elocation-id>1608</elocation-id><pub-id pub-id-type="doi">10.3390/antiox10101608</pub-id><pub-id pub-id-type="pmid">34679742</pub-id>
</element-citation>
      </ref>
      <ref id="B44-biomolecules-14-00206">
        <label>44.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Orrico</surname><given-names>F.</given-names></name>
<name><surname>Laurance</surname><given-names>S.</given-names></name>
<name><surname>Lopez</surname><given-names>A.C.</given-names></name>
<name><surname>Lefevre</surname><given-names>S.D.</given-names></name>
<name><surname>Thomson</surname><given-names>L.</given-names></name>
<name><surname>M&#xF6;ller</surname><given-names>M.N.</given-names></name>
<name><surname>Ostuni</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Oxidative Stress in Healthy and Pathological Red Blood Cells</article-title><source>Biomolecules</source><year>2023</year><volume>13</volume><elocation-id>1262</elocation-id><pub-id pub-id-type="doi">10.3390/biom13081262</pub-id><pub-id pub-id-type="pmid">37627327</pub-id>
</element-citation>
      </ref>
      <ref id="B45-biomolecules-14-00206">
        <label>45.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papanikolaou</surname><given-names>G.</given-names></name>
<name><surname>Pantopoulos</surname><given-names>K.</given-names></name>
</person-group><article-title>Iron Metabolism and Toxicity</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2005</year><volume>202</volume><fpage>199</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2004.06.021</pub-id><pub-id pub-id-type="pmid">15629195</pub-id>
</element-citation>
      </ref>
      <ref id="B46-biomolecules-14-00206">
        <label>46.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thom</surname><given-names>C.S.</given-names></name>
<name><surname>Dickson</surname><given-names>C.F.</given-names></name>
<name><surname>Gell</surname><given-names>D.A.</given-names></name>
<name><surname>Weiss</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Hemoglobin Variants: Biochemical Properties and Clinical Correlates</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2013</year><volume>3</volume><fpage>a011858</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a011858</pub-id><pub-id pub-id-type="pmid">23388674</pub-id>
</element-citation>
      </ref>
      <ref id="B47-biomolecules-14-00206">
        <label>47.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panday</surname><given-names>A.</given-names></name>
<name><surname>Sahoo</surname><given-names>M.K.</given-names></name>
<name><surname>Osorio</surname><given-names>D.</given-names></name>
<name><surname>Batra</surname><given-names>S.</given-names></name>
</person-group><article-title>NADPH Oxidases: An Overview from Structure to Innate Immunity-Associated Pathologies</article-title><source>Cell. Mol. Immunol.</source><year>2014</year><volume>12</volume><fpage>5</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/cmi.2014.89</pub-id><pub-id pub-id-type="pmid">25263488</pub-id>
</element-citation>
      </ref>
      <ref id="B48-biomolecules-14-00206">
        <label>48.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iles</surname><given-names>K.E.</given-names></name>
<name><surname>Forman</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Macrophage Signaling and Respiratory Burst</article-title><source>Immunol. Res.</source><year>2002</year><volume>26</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1385/IR:26:1-3:095</pub-id><pub-id pub-id-type="pmid">12403349</pub-id>
</element-citation>
      </ref>
      <ref id="B49-biomolecules-14-00206">
        <label>49.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nauseef</surname><given-names>W.M.</given-names></name>
</person-group><article-title>Biological Roles for the NOX Family NADPH Oxidases</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>16961</fpage><lpage>16965</lpage><pub-id pub-id-type="doi">10.1074/jbc.R700045200</pub-id><pub-id pub-id-type="pmid">18420576</pub-id>
</element-citation>
      </ref>
      <ref id="B50-biomolecules-14-00206">
        <label>50.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schr&#xF6;der</surname><given-names>K.</given-names></name>
</person-group><article-title>NADPH Oxidases: Current Aspects and Tools</article-title><source>Redox Biol</source><year>2020</year><volume>34</volume><elocation-id>101512</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2020.101512</pub-id><pub-id pub-id-type="pmid">32480354</pub-id>
</element-citation>
      </ref>
      <ref id="B51-biomolecules-14-00206">
        <label>51.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matute</surname><given-names>J.D.</given-names></name>
<name><surname>Arias</surname><given-names>A.A.</given-names></name>
<name><surname>Wright</surname><given-names>N.A.M.</given-names></name>
<name><surname>Wrobel</surname><given-names>I.</given-names></name>
<name><surname>Waterhouse</surname><given-names>C.C.M.</given-names></name>
<name><surname>Li</surname><given-names>X.J.</given-names></name>
<name><surname>Marchal</surname><given-names>C.C.</given-names></name>
<name><surname>Stull</surname><given-names>N.D.</given-names></name>
<name><surname>Lewis</surname><given-names>D.B.</given-names></name>
<name><surname>Steele</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>A New Genetic Subgroup of Chronic Granulomatous Disease with Autosomal Recessive Mutations in p40phox and Selective Defects in Neutrophil NADPH Oxidase Activity</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>3309</fpage><lpage>3315</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-07-231498</pub-id><pub-id pub-id-type="pmid">19692703</pub-id>
</element-citation>
      </ref>
      <ref id="B52-biomolecules-14-00206">
        <label>52.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x2019;Neill</surname><given-names>S.</given-names></name>
<name><surname>Brault</surname><given-names>J.</given-names></name>
<name><surname>Stasia</surname><given-names>M.-J.</given-names></name>
<name><surname>Knaus</surname><given-names>U.G.</given-names></name>
</person-group><article-title>Genetic Disorders Coupled to ROS Deficiency</article-title><source>Redox. Biol.</source><year>2015</year><volume>6</volume><fpage>135</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.07.009</pub-id><pub-id pub-id-type="pmid">26210446</pub-id>
</element-citation>
      </ref>
      <ref id="B53-biomolecules-14-00206">
        <label>53.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zurro</surname><given-names>N.B.</given-names></name>
<name><surname>Tavares de Albuquerque</surname><given-names>J.A.</given-names></name>
<name><surname>Fran&#xE7;a</surname><given-names>T.T.</given-names></name>
<name><surname>Vendramini</surname><given-names>P.</given-names></name>
<name><surname>Arslanian</surname><given-names>C.</given-names></name>
<name><surname>Tavares-Scancetti</surname><given-names>F.</given-names></name>
<name><surname>Condino-Neto</surname><given-names>A.</given-names></name>
</person-group><article-title>A Novel Mutation in <italic toggle="yes">CYBB</italic> Gene in a Patient with Chronic Colitis and Recurrent Pneumonia due to X-Linked Chronic Granulomatous Disease</article-title><source>Pediatr. Blood Cancer</source><year>2018</year><volume>65</volume><fpage>e27382</fpage><pub-id pub-id-type="doi">10.1002/pbc.27382</pub-id><pub-id pub-id-type="pmid">30094936</pub-id>
</element-citation>
      </ref>
      <ref id="B54-biomolecules-14-00206">
        <label>54.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bustamante</surname><given-names>J.</given-names></name>
<name><surname>Picard</surname><given-names>C.</given-names></name>
<name><surname>Fieschi</surname><given-names>C.</given-names></name>
<name><surname>Filipe-Santos</surname><given-names>O.</given-names></name>
<name><surname>Feinberg</surname><given-names>J.</given-names></name>
<name><surname>Perronne</surname><given-names>C.</given-names></name>
<name><surname>Chapgier</surname><given-names>A.</given-names></name>
<name><surname>de Beaucoudrey</surname><given-names>L.</given-names></name>
<name><surname>Vogt</surname><given-names>G.</given-names></name>
<name><surname>Sanlaville</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>A Novel X-Linked Recessive Form of Mendelian Susceptibility to Mycobaterial Disease</article-title><source>J. Med. Genet.</source><year>2007</year><volume>44</volume><fpage>e65</fpage><pub-id pub-id-type="doi">10.1136/jmg.2006.043406</pub-id><pub-id pub-id-type="pmid">17293536</pub-id>
</element-citation>
      </ref>
      <ref id="B55-biomolecules-14-00206">
        <label>55.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teimourian</surname><given-names>S.</given-names></name>
<name><surname>Zomorodian</surname><given-names>E.</given-names></name>
<name><surname>Badalzadeh</surname><given-names>M.</given-names></name>
<name><surname>Pouya</surname><given-names>A.</given-names></name>
<name><surname>Kannengiesser</surname><given-names>C.</given-names></name>
<name><surname>Mansouri</surname><given-names>D.</given-names></name>
<name><surname>Cheraghi</surname><given-names>T.</given-names></name>
<name><surname>Parvaneh</surname><given-names>N.</given-names></name>
</person-group><article-title>Characterization of Six Novel Mutations in <italic toggle="yes">CYBA</italic>: The Gene Causing Autosomal Recessive Chronic Granulomatous Disease</article-title><source>Br. J. Haematol.</source><year>2008</year><volume>141</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.2008.07148.x</pub-id><pub-id pub-id-type="pmid">18422995</pub-id>
</element-citation>
      </ref>
      <ref id="B56-biomolecules-14-00206">
        <label>56.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Curnutte</surname><given-names>J.T.</given-names></name>
<name><surname>Berkow</surname><given-names>R.L.</given-names></name>
<name><surname>Roberts</surname><given-names>R.L.</given-names></name>
<name><surname>Shurin</surname><given-names>S.B.</given-names></name>
<name><surname>Scott</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Chronic Granulomatous Disease due to a Defect in the Cytosolic Factor Required for Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activation</article-title><source>J. Clin. Investig.</source><year>1988</year><volume>81</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1172/JCI113360</pub-id><pub-id pub-id-type="pmid">3339133</pub-id>
</element-citation>
      </ref>
      <ref id="B57-biomolecules-14-00206">
        <label>57.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pati&#xF1;o</surname><given-names>P.J.</given-names></name>
<name><surname>Rae</surname><given-names>J.</given-names></name>
<name><surname>Noack</surname><given-names>D.</given-names></name>
<name><surname>Erickson</surname><given-names>R.</given-names></name>
<name><surname>Ding</surname><given-names>J.</given-names></name>
<name><surname>de Olarte</surname><given-names>D.G.</given-names></name>
<name><surname>Curnutte</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Molecular Characterization of Autosomal Recessive Chronic Granulomatous Disease Caused by a Defect of the Nicotinamide Adenine Dinucleotide Phosphate (reduced Form) Oxidase Component p67-Phox</article-title><source>Blood</source><year>1999</year><volume>94</volume><fpage>2505</fpage><lpage>2514</lpage><pub-id pub-id-type="doi">10.1182/blood.V94.7.2505.419k10_2505_2514</pub-id><pub-id pub-id-type="pmid">10498624</pub-id>
</element-citation>
      </ref>
      <ref id="B58-biomolecules-14-00206">
        <label>58.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van de Geer</surname><given-names>A.</given-names></name>
<name><surname>Nieto-Patl&#xE1;n</surname><given-names>A.</given-names></name>
<name><surname>Kuhns</surname><given-names>D.B.</given-names></name>
<name><surname>Tool</surname><given-names>A.T.</given-names></name>
<name><surname>Arias</surname><given-names>A.A.</given-names></name>
<name><surname>Bouaziz</surname><given-names>M.</given-names></name>
<name><surname>de Boer</surname><given-names>M.</given-names></name>
<name><surname>Franco</surname><given-names>J.L.</given-names></name>
<name><surname>Gazendam</surname><given-names>R.P.</given-names></name>
<name><surname>van Hamme</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>Inherited p40phox Deficiency Differs from Classic Chronic Granulomatous Disease</article-title><source>J. Clin. Investig.</source><year>2018</year><volume>128</volume><fpage>3957</fpage><lpage>3975</lpage><pub-id pub-id-type="doi">10.1172/JCI97116</pub-id><pub-id pub-id-type="pmid">29969437</pub-id>
</element-citation>
      </ref>
      <ref id="B59-biomolecules-14-00206">
        <label>59.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Oliveira-Junior</surname><given-names>E.B.</given-names></name>
<name><surname>Bustamante</surname><given-names>J.</given-names></name>
<name><surname>Newburger</surname><given-names>P.E.</given-names></name>
<name><surname>Condino-Neto</surname><given-names>A.</given-names></name>
</person-group><article-title>The Human NADPH Oxidase: Primary and Secondary Defects Impairing the Respiratory Burst Function and the Microbicidal Ability of Phagocytes</article-title><source>Scand. J. Immunol.</source><year>2011</year><volume>73</volume><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3083.2010.02501.x</pub-id><pub-id pub-id-type="pmid">21204900</pub-id>
</element-citation>
      </ref>
      <ref id="B60-biomolecules-14-00206">
        <label>60.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>P.</given-names></name>
<name><surname>Dhillon</surname><given-names>S.</given-names></name>
<name><surname>O&#x2019;Neill</surname><given-names>K.</given-names></name>
<name><surname>Thoeni</surname><given-names>C.</given-names></name>
<name><surname>Hui</surname><given-names>K.Y.</given-names></name>
<name><surname>Elkadri</surname><given-names>A.</given-names></name>
<name><surname>Guo</surname><given-names>C.H.</given-names></name>
<name><surname>Kovacic</surname><given-names>L.</given-names></name>
<name><surname>Aviello</surname><given-names>G.</given-names></name>
<name><surname>Alvarez</surname><given-names>L.A.</given-names></name>
<etal/>
</person-group><article-title>Defects in NADPH Oxidase Genes <italic toggle="yes">NOX1</italic> and <italic toggle="yes">DUOX2</italic> in Very Early Onset Inflammatory Bowel Disease</article-title><source>Cell Mol. Gastroenterol. Hepatol.</source><year>2015</year><volume>1</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2015.06.005</pub-id><pub-id pub-id-type="pmid">26301257</pub-id>
</element-citation>
      </ref>
      <ref id="B61-biomolecules-14-00206">
        <label>61.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moreno</surname><given-names>J.C.</given-names></name>
<name><surname>Bikker</surname><given-names>H.</given-names></name>
<name><surname>Kempers</surname><given-names>M.J.E.</given-names></name>
<name><surname>van Trotsenburg</surname><given-names>A.S.P.</given-names></name>
<name><surname>Baas</surname><given-names>F.</given-names></name>
<name><surname>de Vijlder</surname><given-names>J.J.M.</given-names></name>
<name><surname>Vulsma</surname><given-names>T.</given-names></name>
<name><surname>Ris-Stalpers</surname><given-names>C.</given-names></name>
</person-group><article-title>Inactivating Mutations in the Gene for Thyroid Oxidase 2 (<italic toggle="yes">THOX2</italic>) and Congenital Hypothyroidism</article-title><source>N. Engl. J. Med.</source><year>2002</year><volume>347</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa012752</pub-id><pub-id pub-id-type="pmid">12110737</pub-id>
</element-citation>
      </ref>
      <ref id="B62-biomolecules-14-00206">
        <label>62.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zamproni</surname><given-names>I.</given-names></name>
<name><surname>Grasberger</surname><given-names>H.</given-names></name>
<name><surname>Cortinovis</surname><given-names>F.</given-names></name>
<name><surname>Vigone</surname><given-names>M.C.</given-names></name>
<name><surname>Chiumello</surname><given-names>G.</given-names></name>
<name><surname>Mora</surname><given-names>S.</given-names></name>
<name><surname>Onigata</surname><given-names>K.</given-names></name>
<name><surname>Fugazzola</surname><given-names>L.</given-names></name>
<name><surname>Refetoff</surname><given-names>S.</given-names></name>
<name><surname>Persani</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Biallelic Inactivation of the Dual Oxidase Maturation Factor 2 (<italic toggle="yes">DUOXA2</italic>) Gene as a Novel Cause of Congenital Hypothyroidism</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2008</year><volume>93</volume><fpage>605</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-2020</pub-id><pub-id pub-id-type="pmid">18042646</pub-id>
</element-citation>
      </ref>
      <ref id="B63-biomolecules-14-00206">
        <label>63.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Deken</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>D.</given-names></name>
<name><surname>Many</surname><given-names>M.C.</given-names></name>
<name><surname>Costagliola</surname><given-names>S.</given-names></name>
<name><surname>Libert</surname><given-names>F.</given-names></name>
<name><surname>Vassart</surname><given-names>G.</given-names></name>
<name><surname>Dumont</surname><given-names>J.E.</given-names></name>
<name><surname>Miot</surname><given-names>F.</given-names></name>
</person-group><article-title>Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>23227</fpage><lpage>23233</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000916200</pub-id><pub-id pub-id-type="pmid">10806195</pub-id>
</element-citation>
      </ref>
      <ref id="B64-biomolecules-14-00206">
        <label>64.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schultz</surname><given-names>J.</given-names></name>
<name><surname>Kaminker</surname><given-names>K.</given-names></name>
</person-group><article-title>Myeloperoxidase of the Leucocyte of Normal Human Blood. I. Content and Localization</article-title><source>Arch. Biochem. Biophys.</source><year>1962</year><volume>96</volume><fpage>465</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(62)90321-1</pub-id><pub-id pub-id-type="pmid">13909511</pub-id>
</element-citation>
      </ref>
      <ref id="B65-biomolecules-14-00206">
        <label>65.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Metzler</surname><given-names>K.D.</given-names></name>
<name><surname>Fuchs</surname><given-names>T.A.</given-names></name>
<name><surname>Nauseef</surname><given-names>W.M.</given-names></name>
<name><surname>Reumaux</surname><given-names>D.</given-names></name>
<name><surname>Roesler</surname><given-names>J.</given-names></name>
<name><surname>Schulze</surname><given-names>I.</given-names></name>
<name><surname>Wahn</surname><given-names>V.</given-names></name>
<name><surname>Papayannopoulos</surname><given-names>V.</given-names></name>
<name><surname>Zychlinsky</surname><given-names>A.</given-names></name>
</person-group><article-title>Myeloperoxidase Is Required for Neutrophil Extracellular Trap Formation: Implications for Innate Immunity</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>953</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-06-290171</pub-id><pub-id pub-id-type="pmid">20974672</pub-id>
</element-citation>
      </ref>
      <ref id="B66-biomolecules-14-00206">
        <label>66.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bos</surname><given-names>A.</given-names></name>
<name><surname>Wever</surname><given-names>R.</given-names></name>
<name><surname>Roos</surname><given-names>D.</given-names></name>
</person-group><article-title>Characterization and Quantification of the Peroxidase in Human Monocytes</article-title><source>Biochim. Biophys. Acta</source><year>1978</year><volume>525</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/0005-2744(78)90197-3</pub-id><pub-id pub-id-type="pmid">28769</pub-id>
</element-citation>
      </ref>
      <ref id="B67-biomolecules-14-00206">
        <label>67.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Odobasic</surname><given-names>D.</given-names></name>
<name><surname>Kitching</surname><given-names>A.R.</given-names></name>
<name><surname>Holdsworth</surname><given-names>S.R.</given-names></name>
</person-group><article-title>Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase</article-title><source>J. Immunol. Res.</source><year>2016</year><volume>2016</volume><fpage>2349817</fpage><pub-id pub-id-type="doi">10.1155/2016/2349817</pub-id><pub-id pub-id-type="pmid">26904693</pub-id>
</element-citation>
      </ref>
      <ref id="B68-biomolecules-14-00206">
        <label>68.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van der Veen</surname><given-names>B.S.</given-names></name>
<name><surname>de Winther</surname><given-names>M.P.J.</given-names></name>
<name><surname>Heeringa</surname><given-names>P.</given-names></name>
</person-group><article-title>Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease</article-title><source>Antioxid. Redox Signal.</source><year>2009</year><volume>11</volume><fpage>2899</fpage><lpage>2937</lpage><pub-id pub-id-type="doi">10.1089/ars.2009.2538</pub-id><pub-id pub-id-type="pmid">19622015</pub-id>
</element-citation>
      </ref>
      <ref id="B69-biomolecules-14-00206">
        <label>69.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kutter</surname><given-names>D.</given-names></name>
<name><surname>Devaquet</surname><given-names>P.</given-names></name>
<name><surname>Vanderstocken</surname><given-names>G.</given-names></name>
<name><surname>Paulus</surname><given-names>J.M.</given-names></name>
<name><surname>Marchal</surname><given-names>V.</given-names></name>
<name><surname>Gothot</surname><given-names>A.</given-names></name>
</person-group><article-title>Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?</article-title><source>Acta Haematol.</source><year>2000</year><volume>104</volume><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1159/000041062</pub-id><pub-id pub-id-type="pmid">11111115</pub-id>
</element-citation>
      </ref>
      <ref id="B70-biomolecules-14-00206">
        <label>70.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lehrer</surname><given-names>R.I.</given-names></name>
<name><surname>Cline</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Leukocyte Myeloperoxidase Deficiency and Disseminated Candidiasis: The Role of Myeloperoxidase in Resistance to Candida Infection</article-title><source>J. Clin. Investig.</source><year>1969</year><volume>48</volume><fpage>1478</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1172/JCI106114</pub-id><pub-id pub-id-type="pmid">5796360</pub-id>
</element-citation>
      </ref>
      <ref id="B71-biomolecules-14-00206">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Abraityt&#x117;</surname><given-names>S.</given-names></name>
<name><surname>Kotsi</surname><given-names>E.</given-names></name>
<name><surname>Devlin</surname><given-names>L.A.</given-names></name>
<name><surname>Edgar</surname><given-names>J.D.M.</given-names></name>
</person-group>
          <article-title>Unexpected Combination: DiGeorge Syndrome and Myeloperoxidase Deficiency</article-title>
          <source>BMJ Case Rep.</source>
          <year>2020</year>
          <volume>13</volume>
          <fpage>e232741</fpage>
          <pub-id pub-id-type="doi">10.1136/bcr-2019-232741</pub-id>
        </element-citation>
      </ref>
      <ref id="B72-biomolecules-14-00206">
        <label>72.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>H.Y.</given-names></name>
<name><surname>Baek</surname><given-names>B.S.</given-names></name>
<name><surname>Song</surname><given-names>S.H.</given-names></name>
<name><surname>Kim</surname><given-names>M.S.</given-names></name>
<name><surname>Huh</surname><given-names>J.I.</given-names></name>
<name><surname>Shim</surname><given-names>K.H.</given-names></name>
<name><surname>Kim</surname><given-names>K.W.</given-names></name>
<name><surname>Lee</surname><given-names>K.H.</given-names></name>
</person-group><article-title>Xanthine Dehydrogenase/xanthine Oxidase and Oxidative Stress</article-title><source>Age</source><year>1997</year><volume>20</volume><fpage>127</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1007/s11357-997-0012-2</pub-id><pub-id pub-id-type="pmid">23604305</pub-id>
</element-citation>
      </ref>
      <ref id="B73-biomolecules-14-00206">
        <label>73.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nishino</surname><given-names>T.</given-names></name>
<name><surname>Okamoto</surname><given-names>K.</given-names></name>
<name><surname>Eger</surname><given-names>B.T.</given-names></name>
<name><surname>Pai</surname><given-names>E.F.</given-names></name>
<name><surname>Nishino</surname><given-names>T.</given-names></name>
</person-group><article-title>Mammalian Xanthine Oxidoreductase&#x2014;Mechanism of Transition from Xanthine Dehydrogenase to Xanthine Oxidase</article-title><source>FEBS J.</source><year>2008</year><volume>275</volume><fpage>3278</fpage><lpage>3289</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2008.06489.x</pub-id><pub-id pub-id-type="pmid">18513323</pub-id>
</element-citation>
      </ref>
      <ref id="B74-biomolecules-14-00206">
        <label>74.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McCord</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Oxygen-Derived Free Radicals in Postischemic Tissue Injury</article-title><source>N. Engl. J. Med.</source><year>1985</year><volume>312</volume><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">2981404</pub-id>
</element-citation>
      </ref>
      <ref id="B75-biomolecules-14-00206">
        <label>75.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsukasa</surname><given-names>K.</given-names></name>
<name><surname>Toshihiro</surname><given-names>N.</given-names></name>
<name><surname>Motoshi</surname><given-names>K.</given-names></name>
<name><surname>Tatsuo</surname><given-names>H.</given-names></name>
<name><surname>Kusuki</surname><given-names>N.</given-names></name>
</person-group><article-title>Biochemical Studies on the Purine Metabolism of Four Cases with Hereditary Xanthinuria</article-title><source>Clin. Chim. Acta</source><year>1984</year><volume>137</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/0009-8981(84)90179-7</pub-id><pub-id pub-id-type="pmid">6423323</pub-id>
</element-citation>
      </ref>
      <ref id="B76-biomolecules-14-00206">
        <label>76.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sebesta</surname><given-names>I.</given-names></name>
<name><surname>Stiburkova</surname><given-names>B.</given-names></name>
<name><surname>Krijt</surname><given-names>J.</given-names></name>
</person-group><article-title>Hereditary Xanthinuria Is Not so Rare Disorder of Purine Metabolism</article-title><source>Nucleosides Nucleotides Nucleic Acids</source><year>2018</year><volume>37</volume><fpage>324</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1080/15257770.2018.1460478</pub-id><pub-id pub-id-type="pmid">29723117</pub-id>
</element-citation>
      </ref>
      <ref id="B77-biomolecules-14-00206">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>F&#xF6;rstermann</surname><given-names>U.</given-names></name>
</person-group>
          <article-title>Nitric Oxide and Oxidative Stress in Vascular Disease</article-title>
          <source>Pflug. Arch.</source>
          <year>2010</year>
          <volume>459</volume>
          <fpage>923</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="doi">10.1007/s00424-010-0808-2</pub-id>
        </element-citation>
      </ref>
      <ref id="B78-biomolecules-14-00206">
        <label>78.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>F&#xF6;rstermann</surname><given-names>U.</given-names></name>
<name><surname>M&#xFC;nzel</surname><given-names>T.</given-names></name>
</person-group><article-title>Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>1708</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.602532</pub-id><pub-id pub-id-type="pmid">16585403</pub-id>
</element-citation>
      </ref>
      <ref id="B79-biomolecules-14-00206">
        <label>79.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xia</surname><given-names>Y.</given-names></name>
<name><surname>Zweier</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Superoxide and Peroxynitrite Generation from Inducible Nitric Oxide Synthase in Macrophages</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>6954</fpage><lpage>6958</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.13.6954</pub-id><pub-id pub-id-type="pmid">9192673</pub-id>
</element-citation>
      </ref>
      <ref id="B80-biomolecules-14-00206">
        <label>80.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arngr&#xED;msson</surname><given-names>R.</given-names></name>
<name><surname>Hayward</surname><given-names>C.</given-names></name>
<name><surname>Nadaud</surname><given-names>S.</given-names></name>
<name><surname>Baldursd&#xF3;ttir</surname><given-names>A.</given-names></name>
<name><surname>Walker</surname><given-names>J.J.</given-names></name>
<name><surname>Liston</surname><given-names>W.A.</given-names></name>
<name><surname>Bjarnad&#xF3;ttir</surname><given-names>R.I.</given-names></name>
<name><surname>Brock</surname><given-names>D.J.</given-names></name>
<name><surname>Geirsson</surname><given-names>R.T.</given-names></name>
<name><surname>Connor</surname><given-names>J.M.</given-names></name>
<etal/>
</person-group><article-title>Evidence for a Familial Pregnancy-Induced Hypertension Locus in the <italic toggle="yes">eNOS</italic>-Gene Region</article-title><source>Am. J. Hum. Genet.</source><year>1997</year><volume>61</volume><fpage>354</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1086/514843</pub-id><pub-id pub-id-type="pmid">9311740</pub-id>
</element-citation>
      </ref>
      <ref id="B81-biomolecules-14-00206">
        <label>81.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berger</surname><given-names>K.</given-names></name>
<name><surname>St&#xF6;gbauer</surname><given-names>F.</given-names></name>
<name><surname>Stoll</surname><given-names>M.</given-names></name>
<name><surname>Wellmann</surname><given-names>J.</given-names></name>
<name><surname>Huge</surname><given-names>A.</given-names></name>
<name><surname>Cheng</surname><given-names>S.</given-names></name>
<name><surname>Kessler</surname><given-names>C.</given-names></name>
<name><surname>John</surname><given-names>U.</given-names></name>
<name><surname>Assmann</surname><given-names>G.</given-names></name>
<name><surname>Ringelstein</surname><given-names>E.B.</given-names></name>
<etal/>
</person-group><article-title>The glu298asp Polymorphism in the Nitric Oxide Synthase 3 Gene Is Associated with the Risk of Ischemic Stroke in Two Large Independent Case-Control Studies</article-title><source>Hum. Genet.</source><year>2007</year><volume>121</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1007/s00439-006-0302-2</pub-id><pub-id pub-id-type="pmid">17165044</pub-id>
</element-citation>
      </ref>
      <ref id="B82-biomolecules-14-00206">
        <label>82.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gwozdzinski</surname><given-names>K.</given-names></name>
<name><surname>Pieniazek</surname><given-names>A.</given-names></name>
<name><surname>Gwozdzinski</surname><given-names>L.</given-names></name>
</person-group><article-title>Reactive Oxygen Species and Their Involvement in Red Blood Cell Damage in Chronic Kidney Disease</article-title><source>Oxid. Med. Cell. Longev.</source><year>2021</year><volume>2021</volume><fpage>6639199</fpage><pub-id pub-id-type="doi">10.1155/2021/6639199</pub-id><pub-id pub-id-type="pmid">33708334</pub-id>
</element-citation>
      </ref>
      <ref id="B83-biomolecules-14-00206">
        <label>83.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kattamis</surname><given-names>C.A.</given-names></name>
<name><surname>Kyriazakou</surname><given-names>M.</given-names></name>
<name><surname>Chaidas</surname><given-names>S.</given-names></name>
</person-group><article-title>Favism: Clinical and Biochemical Data</article-title><source>J. Med. Genet.</source><year>1969</year><volume>6</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1136/jmg.6.1.34</pub-id><pub-id pub-id-type="pmid">5771221</pub-id>
</element-citation>
      </ref>
      <ref id="B84-biomolecules-14-00206">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ighodaro</surname><given-names>O.M.</given-names></name>
<name><surname>Akinloye</surname><given-names>O.A.</given-names></name>
</person-group>
          <article-title>First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid</article-title>
          <source>Alex. J. Med.</source>
          <year>2018</year>
          <volume>54</volume>
          <fpage>287</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajme.2017.09.001</pub-id>
        </element-citation>
      </ref>
      <ref id="B85-biomolecules-14-00206">
        <label>85.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Graves</surname><given-names>J.A.</given-names></name>
<name><surname>Metukuri</surname><given-names>M.</given-names></name>
<name><surname>Scott</surname><given-names>D.</given-names></name>
<name><surname>Rothermund</surname><given-names>K.</given-names></name>
<name><surname>Prochownik</surname><given-names>E.V.</given-names></name>
</person-group><article-title>Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>6520</fpage><lpage>6529</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807564200</pub-id><pub-id pub-id-type="pmid">19098005</pub-id>
</element-citation>
      </ref>
      <ref id="B86-biomolecules-14-00206">
        <label>86.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Talwar</surname><given-names>D.</given-names></name>
<name><surname>Miller</surname><given-names>C.G.</given-names></name>
<name><surname>Grossmann</surname><given-names>J.</given-names></name>
<name><surname>Szyrwiel</surname><given-names>L.</given-names></name>
<name><surname>Schwecke</surname><given-names>T.</given-names></name>
<name><surname>Demichev</surname><given-names>V.</given-names></name>
<name><surname>Mikecin Drazic</surname><given-names>A.-M.</given-names></name>
<name><surname>Mayakonda</surname><given-names>A.</given-names></name>
<name><surname>Lutsik</surname><given-names>P.</given-names></name>
<name><surname>Veith</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>The GAPDH Redox Switch Safeguards Reductive Capacity and Enables Survival of Stressed Tumour Cells</article-title><source>Nat. Metab.</source><year>2023</year><volume>5</volume><fpage>660</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/s42255-023-00781-3</pub-id><pub-id pub-id-type="pmid">37024754</pub-id>
</element-citation>
      </ref>
      <ref id="B87-biomolecules-14-00206">
        <label>87.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Modun</surname><given-names>D.</given-names></name>
<name><surname>Giustarini</surname><given-names>D.</given-names></name>
<name><surname>Tsikas</surname><given-names>D.</given-names></name>
</person-group><article-title>Nitric Oxide-Related Oxidative Stress and Redox Status in Health and Disease</article-title><source>Oxid. Med. Cell. Longev.</source><year>2014</year><volume>2014</volume><fpage>129651</fpage><pub-id pub-id-type="doi">10.1155/2014/129651</pub-id><pub-id pub-id-type="pmid">25170388</pub-id>
</element-citation>
      </ref>
      <ref id="B88-biomolecules-14-00206">
        <label>88.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ralser</surname><given-names>M.</given-names></name>
<name><surname>Wamelink</surname><given-names>M.M.</given-names></name>
<name><surname>Kowald</surname><given-names>A.</given-names></name>
<name><surname>Gerisch</surname><given-names>B.</given-names></name>
<name><surname>Heeren</surname><given-names>G.</given-names></name>
<name><surname>Struys</surname><given-names>E.A.</given-names></name>
<name><surname>Klipp</surname><given-names>E.</given-names></name>
<name><surname>Jakobs</surname><given-names>C.</given-names></name>
<name><surname>Breitenbach</surname><given-names>M.</given-names></name>
<name><surname>Lehrach</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Dynamic Rerouting of the Carbohydrate Flux Is Key to Counteracting Oxidative Stress</article-title><source>J. Biol.</source><year>2007</year><volume>6</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/jbiol61</pub-id><pub-id pub-id-type="pmid">18154684</pub-id>
</element-citation>
      </ref>
      <ref id="B89-biomolecules-14-00206">
        <label>89.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ralser</surname><given-names>M.</given-names></name>
<name><surname>Wamelink</surname><given-names>M.M.C.</given-names></name>
<name><surname>Latkolik</surname><given-names>S.</given-names></name>
<name><surname>Jansen</surname><given-names>E.E.W.</given-names></name>
<name><surname>Lehrach</surname><given-names>H.</given-names></name>
<name><surname>Jakobs</surname><given-names>C.</given-names></name>
</person-group><article-title>Metabolic Reconfiguration Precedes Transcriptional Regulation in the Antioxidant Response</article-title><source>Nat. Biotechnol.</source><year>2009</year><volume>27</volume><fpage>604</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/nbt0709-604</pub-id><pub-id pub-id-type="pmid">19587661</pub-id>
</element-citation>
      </ref>
      <ref id="B90-biomolecules-14-00206">
        <label>90.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grune</surname><given-names>T.</given-names></name>
</person-group><article-title>Oxidants and Antioxidative Defense</article-title><source>Hum. Exp. Toxicol.</source><year>2002</year><volume>21</volume><fpage>61</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1191/0960327102ht210oa</pub-id><pub-id pub-id-type="pmid">12102496</pub-id>
</element-citation>
      </ref>
      <ref id="B91-biomolecules-14-00206">
        <label>91.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Holmgren</surname><given-names>A.</given-names></name>
</person-group><article-title>The Thioredoxin Antioxidant System</article-title><source>Free Radic. Biol. Med.</source><year>2014</year><volume>66</volume><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.07.036</pub-id><pub-id pub-id-type="pmid">23899494</pub-id>
</element-citation>
      </ref>
      <ref id="B92-biomolecules-14-00206">
        <label>92.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lubos</surname><given-names>E.</given-names></name>
<name><surname>Loscalzo</surname><given-names>J.</given-names></name>
<name><surname>Handy</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities</article-title><source>Antioxid. Redox Signal.</source><year>2011</year><volume>15</volume><fpage>1957</fpage><lpage>1997</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3586</pub-id><pub-id pub-id-type="pmid">21087145</pub-id>
</element-citation>
      </ref>
      <ref id="B93-biomolecules-14-00206">
        <label>93.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berdy&#x144;ski</surname><given-names>M.</given-names></name>
<name><surname>Miszta</surname><given-names>P.</given-names></name>
<name><surname>Safranow</surname><given-names>K.</given-names></name>
<name><surname>Andersen</surname><given-names>P.M.</given-names></name>
<name><surname>Morita</surname><given-names>M.</given-names></name>
<name><surname>Filipek</surname><given-names>S.</given-names></name>
<name><surname>&#x17B;ekanowski</surname><given-names>C.</given-names></name>
<name><surname>Ku&#x17A;ma-Kozakiewicz</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">SOD1</italic> Mutations Associated with Amyotrophic Lateral Sclerosis Analysis of Variant Severity</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-03891-8</pub-id><pub-id pub-id-type="pmid">34996976</pub-id>
</element-citation>
      </ref>
      <ref id="B94-biomolecules-14-00206">
        <label>94.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Culik</surname><given-names>R.M.</given-names></name>
<name><surname>Sekhar</surname><given-names>A.</given-names></name>
<name><surname>Nagesh</surname><given-names>J.</given-names></name>
<name><surname>Deol</surname><given-names>H.</given-names></name>
<name><surname>Rumfeldt</surname><given-names>J.A.O.</given-names></name>
<name><surname>Meiering</surname><given-names>E.M.</given-names></name>
<name><surname>Kay</surname><given-names>L.E.</given-names></name>
</person-group><article-title>Effects of Maturation on the Conformational Free-Energy Landscape of SOD1</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>E2546</fpage><lpage>E2555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1721022115</pub-id><pub-id pub-id-type="pmid">29483249</pub-id>
</element-citation>
      </ref>
      <ref id="B95-biomolecules-14-00206">
        <label>95.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sau</surname><given-names>D.</given-names></name>
<name><surname>De Biasi</surname><given-names>S.</given-names></name>
<name><surname>Vitellaro-Zuccarello</surname><given-names>L.</given-names></name>
<name><surname>Riso</surname><given-names>P.</given-names></name>
<name><surname>Guarnieri</surname><given-names>S.</given-names></name>
<name><surname>Porrini</surname><given-names>M.</given-names></name>
<name><surname>Simeoni</surname><given-names>S.</given-names></name>
<name><surname>Crippa</surname><given-names>V.</given-names></name>
<name><surname>Onesto</surname><given-names>E.</given-names></name>
<name><surname>Palazzolo</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Mutation of SOD1 in ALS: A Gain of a Loss of Function</article-title><source>Hum. Mol. Genet.</source><year>2007</year><volume>16</volume><fpage>1604</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddm110</pub-id><pub-id pub-id-type="pmid">17504823</pub-id>
</element-citation>
      </ref>
      <ref id="B96-biomolecules-14-00206">
        <label>96.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valentine</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Do Oxidatively Modified Proteins Cause ALS?</article-title><source>Free Radic. Biol. Med.</source><year>2002</year><volume>33</volume><fpage>1314</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(02)01080-8</pub-id><pub-id pub-id-type="pmid">12419463</pub-id>
</element-citation>
      </ref>
      <ref id="B97-biomolecules-14-00206">
        <label>97.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ezer</surname><given-names>S.</given-names></name>
<name><surname>Daana</surname><given-names>M.</given-names></name>
<name><surname>Park</surname><given-names>J.H.</given-names></name>
<name><surname>Yanovsky-Dagan</surname><given-names>S.</given-names></name>
<name><surname>Nordstr&#xF6;m</surname><given-names>U.</given-names></name>
<name><surname>Basal</surname><given-names>A.</given-names></name>
<name><surname>Edvardson</surname><given-names>S.</given-names></name>
<name><surname>Saada</surname><given-names>A.</given-names></name>
<name><surname>Otto</surname><given-names>M.</given-names></name>
<name><surname>Meiner</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>Infantile SOD1 Deficiency Syndrome Caused by a Homozygous <italic toggle="yes">SOD1</italic> Variant with Absence of Enzyme Activity</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>872</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1093/brain/awab416</pub-id><pub-id pub-id-type="pmid">34788402</pub-id>
</element-citation>
      </ref>
      <ref id="B98-biomolecules-14-00206">
        <label>98.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>P.M.</given-names></name>
<name><surname>Nordstr&#xF6;m</surname><given-names>U.</given-names></name>
<name><surname>Tsiakas</surname><given-names>K.</given-names></name>
<name><surname>Johannsen</surname><given-names>J.</given-names></name>
<name><surname>Volk</surname><given-names>A.E.</given-names></name>
<name><surname>Bierhals</surname><given-names>T.</given-names></name>
<name><surname>Zetterstr&#xF6;m</surname><given-names>P.</given-names></name>
<name><surname>Marklund</surname><given-names>S.L.</given-names></name>
<name><surname>Hempel</surname><given-names>M.</given-names></name>
<name><surname>Santer</surname><given-names>R.</given-names></name>
</person-group><article-title>Phenotype in an Infant with <italic toggle="yes">SOD1</italic> Homozygous Truncating Mutation</article-title><source>N. Engl. J. Med.</source><year>2019</year><volume>381</volume><fpage>486</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1905039</pub-id><pub-id pub-id-type="pmid">31314961</pub-id>
</element-citation>
      </ref>
      <ref id="B99-biomolecules-14-00206">
        <label>99.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>J.H.</given-names></name>
<name><surname>Elpers</surname><given-names>C.</given-names></name>
<name><surname>Reunert</surname><given-names>J.</given-names></name>
<name><surname>McCormick</surname><given-names>M.L.</given-names></name>
<name><surname>Mohr</surname><given-names>J.</given-names></name>
<name><surname>Biskup</surname><given-names>S.</given-names></name>
<name><surname>Schwartz</surname><given-names>O.</given-names></name>
<name><surname>Rust</surname><given-names>S.</given-names></name>
<name><surname>Gr&#xFC;neberg</surname><given-names>M.</given-names></name>
<name><surname>Seelh&#xF6;fer</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>SOD1 Deficiency: A Novel Syndrome Distinct from Amyotrophic Lateral Sclerosis</article-title><source>Brain</source><year>2019</year><volume>142</volume><fpage>2230</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.1093/brain/awz182</pub-id><pub-id pub-id-type="pmid">31332433</pub-id>
</element-citation>
      </ref>
      <ref id="B100-biomolecules-14-00206">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Smejkal</surname><given-names>G.B.</given-names></name>
<name><surname>Kakumanu</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Enzymes and Their Turnover Numbers</article-title>
          <source>Expert Rev. Proteom.</source>
          <year>2019</year>
          <volume>16</volume>
          <fpage>543</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="doi">10.1080/14789450.2019.1630275</pub-id>
        </element-citation>
      </ref>
      <ref id="B101-biomolecules-14-00206">
        <label>101.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ogata</surname><given-names>M.</given-names></name>
</person-group><article-title>Acatalasemia</article-title><source>Hum. Genet.</source><year>1991</year><volume>86</volume><fpage>331</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1007/BF00201829</pub-id><pub-id pub-id-type="pmid">1999334</pub-id>
</element-citation>
      </ref>
      <ref id="B102-biomolecules-14-00206">
        <label>102.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takahara</surname><given-names>S.</given-names></name>
</person-group><article-title>Progressive Oral Gangrene Probably due to Lack of Catalase in the Blood (acatalasaemia); Report of Nine Cases</article-title><source>Lancet</source><year>1952</year><volume>2</volume><fpage>1101</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(52)90939-2</pub-id><pub-id pub-id-type="pmid">12991731</pub-id>
</element-citation>
      </ref>
      <ref id="B103-biomolecules-14-00206">
        <label>103.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Ludlow</surname><given-names>J.T.</given-names></name>
<name><surname>Wilkerson</surname><given-names>R.G.</given-names></name>
<name><surname>Nappe</surname><given-names>T.M.</given-names></name>
</person-group>
          <source>Methemoglobinemia</source>
          <publisher-name>StatPearls Publishing</publisher-name>
          <publisher-loc>Treasure Island, FL, USA</publisher-loc>
          <year>2023</year>
        </element-citation>
      </ref>
      <ref id="B104-biomolecules-14-00206">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Takahara</surname><given-names>S.</given-names></name>
<name><surname>Ogata</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Metabolism in Japanese Acatalasemia with Special Reference to Superoxide Dismutase and Glutathione Peroxidase</article-title>
          <source>Biochem. Med. Asp. Act. Oxyg.</source>
          <year>1978</year>
          <volume>3</volume>
          <fpage>279</fpage>
          <lpage>292</lpage>
        </element-citation>
      </ref>
      <ref id="B105-biomolecules-14-00206">
        <label>105.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>G&#xF3;th</surname><given-names>L.</given-names></name>
<name><surname>Nagy</surname><given-names>T.</given-names></name>
</person-group><article-title>Inherited Catalase Deficiency: Is It Benign or a Factor in Various Age Related Disorders?</article-title><source>Mutat. Res.</source><year>2013</year><volume>753</volume><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.mrrev.2013.08.002</pub-id><pub-id pub-id-type="pmid">24025477</pub-id>
</element-citation>
      </ref>
      <ref id="B106-biomolecules-14-00206">
        <label>106.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nandi</surname><given-names>A.</given-names></name>
<name><surname>Yan</surname><given-names>L.-J.</given-names></name>
<name><surname>Jana</surname><given-names>C.K.</given-names></name>
<name><surname>Das</surname><given-names>N.</given-names></name>
</person-group><article-title>Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases</article-title><source>Oxid. Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>9613090</fpage><pub-id pub-id-type="doi">10.1155/2019/9613090</pub-id><pub-id pub-id-type="pmid">31827713</pub-id>
</element-citation>
      </ref>
      <ref id="B107-biomolecules-14-00206">
        <label>107.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brigelius-Floh&#xE9;</surname><given-names>R.</given-names></name>
<name><surname>Maiorino</surname><given-names>M.</given-names></name>
</person-group><article-title>Glutathione Peroxidases</article-title><source>Biochim. Biophys. Acta</source><year>2013</year><volume>1830</volume><fpage>3289</fpage><lpage>3303</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2012.11.020</pub-id><pub-id pub-id-type="pmid">23201771</pub-id>
</element-citation>
      </ref>
      <ref id="B108-biomolecules-14-00206">
        <label>108.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Necheles</surname><given-names>T.F.</given-names></name>
<name><surname>Maldonado</surname><given-names>N.</given-names></name>
<name><surname>Barquet-Chediak</surname><given-names>A.</given-names></name>
<name><surname>Allen</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Homozygous Erythrocyte Glutathione-Peroxidase Deficiency: Clinical and Biochemical Studies</article-title><source>Blood</source><year>1969</year><volume>33</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1182/blood.V33.2.164.164</pub-id><pub-id pub-id-type="pmid">5766310</pub-id>
</element-citation>
      </ref>
      <ref id="B109-biomolecules-14-00206">
        <label>109.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fibach</surname><given-names>E.</given-names></name>
<name><surname>Rachmilewitz</surname><given-names>E.</given-names></name>
</person-group><article-title>The Role of Oxidative Stress in Hemolytic Anemia</article-title><source>Curr. Mol. Med.</source><year>2008</year><volume>8</volume><fpage>609</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.2174/156652408786241384</pub-id><pub-id pub-id-type="pmid">18991647</pub-id>
</element-citation>
      </ref>
      <ref id="B110-biomolecules-14-00206">
        <label>110.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sedaghatian</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Congenital Lethal Metaphyseal Chondrodysplasia: A Newly Recognized Complex Autosomal Recessive Disorder</article-title><source>Am. J. Med. Genet.</source><year>1980</year><volume>6</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1002/ajmg.1320060403</pub-id><pub-id pub-id-type="pmid">7211944</pub-id>
</element-citation>
      </ref>
      <ref id="B111-biomolecules-14-00206">
        <label>111.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peshimam</surname><given-names>N.</given-names></name>
<name><surname>Farah</surname><given-names>H.</given-names></name>
<name><surname>Caswell</surname><given-names>R.</given-names></name>
<name><surname>Ellard</surname><given-names>S.</given-names></name>
<name><surname>Jan</surname><given-names>W.</given-names></name>
<name><surname>Calder</surname><given-names>A.D.</given-names></name>
<name><surname>Cobben</surname><given-names>J.</given-names></name>
<name><surname>Kariholu</surname><given-names>U.</given-names></name>
<name><surname>Leitch</surname><given-names>H.G.</given-names></name>
</person-group><article-title>Sedaghatian Spondylometaphyseal Dysplasia in Two Siblings</article-title><source>Eur. J. Med. Genet.</source><year>2022</year><volume>65</volume><fpage>104541</fpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2022.104541</pub-id><pub-id pub-id-type="pmid">35718083</pub-id>
</element-citation>
      </ref>
      <ref id="B112-biomolecules-14-00206">
        <label>112.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Friedmann Angeli</surname><given-names>J.P.</given-names></name>
<name><surname>Schneider</surname><given-names>M.</given-names></name>
<name><surname>Proneth</surname><given-names>B.</given-names></name>
<name><surname>Tyurina</surname><given-names>Y.Y.</given-names></name>
<name><surname>Tyurin</surname><given-names>V.A.</given-names></name>
<name><surname>Hammond</surname><given-names>V.J.</given-names></name>
<name><surname>Herbach</surname><given-names>N.</given-names></name>
<name><surname>Aichler</surname><given-names>M.</given-names></name>
<name><surname>Walch</surname><given-names>A.</given-names></name>
<name><surname>Eggenhofer</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Inactivation of the Ferroptosis Regulator Gpx4 Triggers Acute Renal Failure in Mice</article-title><source>Nat. Cell Biol.</source><year>2014</year><volume>16</volume><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/ncb3064</pub-id><pub-id pub-id-type="pmid">25402683</pub-id>
</element-citation>
      </ref>
      <ref id="B113-biomolecules-14-00206">
        <label>113.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fedida</surname><given-names>A.</given-names></name>
<name><surname>Ben Harouch</surname><given-names>S.</given-names></name>
<name><surname>Kalfon</surname><given-names>L.</given-names></name>
<name><surname>Abunassar</surname><given-names>Z.</given-names></name>
<name><surname>Omari</surname><given-names>H.</given-names></name>
<name><surname>Mandel</surname><given-names>H.</given-names></name>
<name><surname>Falik-Zaccai</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Sedaghatian-Type Spondylometaphyseal Dysplasia: Whole Exome Sequencing in Neonatal Dry Blood Spots Enabled Identification of a Novel Variant in <italic toggle="yes">GPX4</italic></article-title><source>Eur. J. Med. Genet.</source><year>2020</year><volume>63</volume><fpage>104020</fpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2020.104020</pub-id><pub-id pub-id-type="pmid">32827718</pub-id>
</element-citation>
      </ref>
      <ref id="B114-biomolecules-14-00206">
        <label>114.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perkins</surname><given-names>A.</given-names></name>
<name><surname>Nelson</surname><given-names>K.J.</given-names></name>
<name><surname>Parsonage</surname><given-names>D.</given-names></name>
<name><surname>Poole</surname><given-names>L.B.</given-names></name>
<name><surname>Karplus</surname><given-names>P.A.</given-names></name>
</person-group><article-title>Peroxiredoxins: Guardians against Oxidative Stress and Modulators of Peroxide Signaling</article-title><source>Trends Biochem. Sci.</source><year>2015</year><volume>40</volume><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2015.05.001</pub-id><pub-id pub-id-type="pmid">26067716</pub-id>
</element-citation>
      </ref>
      <ref id="B115-biomolecules-14-00206">
        <label>115.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiribau</surname><given-names>C.B.</given-names></name>
<name><surname>Cheng</surname><given-names>L.</given-names></name>
<name><surname>Cucoranu</surname><given-names>I.C.</given-names></name>
<name><surname>Yu</surname><given-names>Y.-S.</given-names></name>
<name><surname>Clempus</surname><given-names>R.E.</given-names></name>
<name><surname>Sorescu</surname><given-names>D.</given-names></name>
</person-group><article-title>FOXO3A Regulates Peroxiredoxin III Expression in Human Cardiac Fibroblasts</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>8211</fpage><lpage>8217</lpage><pub-id pub-id-type="doi">10.1074/jbc.M710610200</pub-id><pub-id pub-id-type="pmid">18195003</pub-id>
</element-citation>
      </ref>
      <ref id="B116-biomolecules-14-00206">
        <label>116.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rebelo</surname><given-names>A.P.</given-names></name>
<name><surname>Eidhof</surname><given-names>I.</given-names></name>
<name><surname>Cintra</surname><given-names>V.P.</given-names></name>
<name><surname>Guillot-Noel</surname><given-names>L.</given-names></name>
<name><surname>Pereira</surname><given-names>C.V.</given-names></name>
<name><surname>Timmann</surname><given-names>D.</given-names></name>
<name><surname>Trasch&#xFC;tz</surname><given-names>A.</given-names></name>
<name><surname>Sch&#xF6;ls</surname><given-names>L.</given-names></name>
<name><surname>Coarelli</surname><given-names>G.</given-names></name>
<name><surname>Durr</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Biallelic Loss-of-Function Variations in <italic toggle="yes">PRDX3</italic> Cause Cerebellar Ataxia</article-title><source>Brain</source><year>2021</year><volume>144</volume><fpage>1467</fpage><lpage>1481</lpage><pub-id pub-id-type="doi">10.1093/brain/awab071</pub-id><pub-id pub-id-type="pmid">33889951</pub-id>
</element-citation>
      </ref>
      <ref id="B117-biomolecules-14-00206">
        <label>117.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rebelo</surname><given-names>A.P.</given-names></name>
<name><surname>Bender</surname><given-names>B.</given-names></name>
<name><surname>Haack</surname><given-names>T.B.</given-names></name>
<name><surname>Zuchner</surname><given-names>S.</given-names></name>
<collab>PREPARE consortium</collab>
<name><surname>Basak</surname><given-names>A.N.</given-names></name>
<name><surname>Synofzik</surname><given-names>M.</given-names></name>
</person-group><article-title>Expanding PRDX3 Disease: Broad Range of Onset Age and Infratentorial MRI Signal Changes</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>e95</fpage><lpage>e98</lpage><pub-id pub-id-type="doi">10.1093/brain/awac240</pub-id><pub-id pub-id-type="pmid">35792670</pub-id>
</element-citation>
      </ref>
      <ref id="B118-biomolecules-14-00206">
        <label>118.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mart&#xED;nez-Rubio</surname><given-names>D.</given-names></name>
<name><surname>Rodr&#xED;guez-Prieto</surname><given-names>&#xC1;.</given-names></name>
<name><surname>Sancho</surname><given-names>P.</given-names></name>
<name><surname>Navarro-Gonz&#xE1;lez</surname><given-names>C.</given-names></name>
<name><surname>Gorr&#xED;a-Redondo</surname><given-names>N.</given-names></name>
<name><surname>Miquel-Leal</surname><given-names>J.</given-names></name>
<name><surname>Marco-Mar&#xED;n</surname><given-names>C.</given-names></name>
<name><surname>Jenkins</surname><given-names>A.</given-names></name>
<name><surname>Soriano-Navarro</surname><given-names>M.</given-names></name>
<name><surname>Hern&#xE1;ndez</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Protein Misfolding and Clearance in the Pathogenesis of a New Infantile Onset Ataxia Caused by Mutations in <italic toggle="yes">PRDX3</italic></article-title><source>Hum. Mol. Genet.</source><year>2022</year><volume>31</volume><fpage>3897</fpage><lpage>3913</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddac146</pub-id><pub-id pub-id-type="pmid">35766882</pub-id>
</element-citation>
      </ref>
      <ref id="B119-biomolecules-14-00206">
        <label>119.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali&#xF3; Del Barrio</surname><given-names>J.L.</given-names></name>
<name><surname>Chung</surname><given-names>D.D.</given-names></name>
<name><surname>Al-Shymali</surname><given-names>O.</given-names></name>
<name><surname>Barrington</surname><given-names>A.</given-names></name>
<name><surname>Jatavallabhula</surname><given-names>K.</given-names></name>
<name><surname>Swamy</surname><given-names>V.S.</given-names></name>
<name><surname>Y&#xE9;bana</surname><given-names>P.</given-names></name>
<name><surname>Ang&#xE9;lica Henr&#xED;quez-Recine</surname><given-names>M.</given-names></name>
<name><surname>Boto-de-Los-Bueis</surname><given-names>A.</given-names></name>
<name><surname>Ali&#xF3;</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy: Clinical Evaluation and Identification of the Genetic Basis</article-title><source>Am. J. Ophthalmol.</source><year>2020</year><volume>212</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2019.11.024</pub-id><pub-id pub-id-type="pmid">31782998</pub-id>
</element-citation>
      </ref>
      <ref id="B120-biomolecules-14-00206">
        <label>120.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Henr&#xED;quez-Recine</surname><given-names>M.A.</given-names></name>
<name><surname>Marquina-Lima</surname><given-names>K.S.</given-names></name>
<name><surname>Vallesp&#xED;n-Garc&#xED;a</surname><given-names>E.</given-names></name>
<name><surname>Garc&#xED;a-Mi&#xF1;aur</surname><given-names>S.</given-names></name>
<name><surname>Benitez Del Castillo</surname><given-names>J.M.</given-names></name>
<name><surname>Boto de Los Bueis</surname><given-names>A.</given-names></name>
</person-group><article-title>Heredity and in Vivo Confocal Microscopy of Punctiform and Polychromatic Pre-Descemet Dystrophy</article-title><source>Graefes Arch. Clin. Exp. Ophthalmol.</source><year>2018</year><volume>256</volume><fpage>1661</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1007/s00417-018-3993-x</pub-id><pub-id pub-id-type="pmid">29728753</pub-id>
</element-citation>
      </ref>
      <ref id="B121-biomolecules-14-00206">
        <label>121.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choo</surname><given-names>C.H.</given-names></name>
<name><surname>Boto de Los Bueis</surname><given-names>A.</given-names></name>
<name><surname>Chung</surname><given-names>D.D.</given-names></name>
<name><surname>Aldave</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Confirmation of PRDX3 c.568G&gt;C as the Genetic Basis of Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy</article-title><source>Cornea</source><year>2022</year><volume>41</volume><fpage>779</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1097/ICO.0000000000002828</pub-id><pub-id pub-id-type="pmid">34369396</pub-id>
</element-citation>
      </ref>
      <ref id="B122-biomolecules-14-00206">
        <label>122.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu&#xE9;ant</surname><given-names>J.-L.</given-names></name>
<name><surname>Ch&#xE9;ry</surname><given-names>C.</given-names></name>
<name><surname>Oussalah</surname><given-names>A.</given-names></name>
<name><surname>Nadaf</surname><given-names>J.</given-names></name>
<name><surname>Coelho</surname><given-names>D.</given-names></name>
<name><surname>Josse</surname><given-names>T.</given-names></name>
<name><surname>Flayac</surname><given-names>J.</given-names></name>
<name><surname>Robert</surname><given-names>A.</given-names></name>
<name><surname>Koscinski</surname><given-names>I.</given-names></name>
<name><surname>Gastin</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">APRDX1</italic> Mutant Allele Causes a MMACHC Secondary Epimutation in cblC Patients</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-02306-5</pub-id><pub-id pub-id-type="pmid">29302025</pub-id>
</element-citation>
      </ref>
      <ref id="B123-biomolecules-14-00206">
        <label>123.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bachhawat</surname><given-names>A.K.</given-names></name>
<name><surname>Yadav</surname><given-names>S.</given-names></name>
</person-group><article-title>The Glutathione Cycle: Glutathione Metabolism beyond the &#x3B3;-Glutamyl Cycle</article-title><source>IUBMB Life</source><year>2018</year><volume>70</volume><fpage>585</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1002/iub.1756</pub-id><pub-id pub-id-type="pmid">29667297</pub-id>
</element-citation>
      </ref>
      <ref id="B124-biomolecules-14-00206">
        <label>124.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Konrad</surname><given-names>P.N.</given-names></name>
<name><surname>Richards</surname><given-names>F.</given-names><suffix>2nd</suffix></name>
<name><surname>Valentine</surname><given-names>W.N.</given-names></name>
<name><surname>Paglia</surname><given-names>D.E.</given-names></name>
</person-group><article-title>-Glutamyl-Cysteine Synthetase Deficiency. A Cause of Hereditary Hemolytic Anemia</article-title><source>N. Engl. J. Med.</source><year>1972</year><volume>286</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1056/NEJM197203162861101</pub-id><pub-id pub-id-type="pmid">5058793</pub-id>
</element-citation>
      </ref>
      <ref id="B125-biomolecules-14-00206">
        <label>125.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hirono</surname><given-names>A.</given-names></name>
<name><surname>Iyori</surname><given-names>H.</given-names></name>
<name><surname>Sekine</surname><given-names>I.</given-names></name>
<name><surname>Ueyama</surname><given-names>J.</given-names></name>
<name><surname>Chiba</surname><given-names>H.</given-names></name>
<name><surname>Kanno</surname><given-names>H.</given-names></name>
<name><surname>Fujii</surname><given-names>H.</given-names></name>
<name><surname>Miwa</surname><given-names>S.</given-names></name>
</person-group><article-title>Three Cases of Hereditary Nonspherocytic Hemolytic Anemia Associated with Red Blood Cell Glutathione Deficiency</article-title><source>Blood</source><year>1996</year><volume>87</volume><fpage>2071</fpage><lpage>2074</lpage><pub-id pub-id-type="doi">10.1182/blood.V87.5.2071.2071</pub-id><pub-id pub-id-type="pmid">8634459</pub-id>
</element-citation>
      </ref>
      <ref id="B126-biomolecules-14-00206">
        <label>126.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohler</surname><given-names>D.N.</given-names></name>
<name><surname>Majerus</surname><given-names>P.W.</given-names></name>
<name><surname>Minnich</surname><given-names>V.</given-names></name>
<name><surname>Hess</surname><given-names>C.E.</given-names></name>
<name><surname>Garrick</surname><given-names>M.D.</given-names></name>
</person-group><article-title>Glutathione Synthetase Deficiency as a Cause of Hereditary Hemolytic Disease</article-title><source>N. Engl. J. Med.</source><year>1970</year><volume>283</volume><fpage>1253</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1056/NEJM197012032832304</pub-id><pub-id pub-id-type="pmid">5476481</pub-id>
</element-citation>
      </ref>
      <ref id="B127-biomolecules-14-00206">
        <label>127.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jellum</surname><given-names>E.</given-names></name>
<name><surname>Kluge</surname><given-names>T.</given-names></name>
<name><surname>B&#xF6;rresen</surname><given-names>H.C.</given-names></name>
<name><surname>Stokke</surname><given-names>O.</given-names></name>
<name><surname>Eldjarn</surname><given-names>L.</given-names></name>
</person-group><article-title>Pyroglutamic Aciduria&#x2014;A New Inborn Error of Metabolism</article-title><source>Scand. J. Clin. Lab. Investig.</source><year>1970</year><volume>26</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.3109/00365517009046241</pub-id><pub-id pub-id-type="pmid">5486400</pub-id>
</element-citation>
      </ref>
      <ref id="B128-biomolecules-14-00206">
        <label>128.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spielberg</surname><given-names>S.P.</given-names></name>
<name><surname>Garrick</surname><given-names>M.D.</given-names></name>
<name><surname>Corash</surname><given-names>L.M.</given-names></name>
<name><surname>Butler</surname><given-names>J.D.</given-names></name>
<name><surname>Tietze</surname><given-names>F.</given-names></name>
<name><surname>Rogers</surname><given-names>L.</given-names></name>
<name><surname>Schulman</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Biochemical Heterogeneity in Glutathione Synthetase Deficiency</article-title><source>J. Clin. Investig.</source><year>1978</year><volume>61</volume><fpage>1417</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1172/JCI109060</pub-id><pub-id pub-id-type="pmid">659603</pub-id>
</element-citation>
      </ref>
      <ref id="B129-biomolecules-14-00206">
        <label>129.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ristoff</surname><given-names>E.</given-names></name>
<name><surname>Hebert</surname><given-names>C.</given-names></name>
<name><surname>Nj&#xE5;lsson</surname><given-names>R.</given-names></name>
<name><surname>Norgren</surname><given-names>S.</given-names></name>
<name><surname>Rooyackers</surname><given-names>O.</given-names></name>
<name><surname>Larsson</surname><given-names>A.</given-names></name>
</person-group><article-title>Glutathione Synthetase Deficiency: Is Gamma-Glutamylcysteine Accumulation a Way to Cope with Oxidative Stress in Cells with Insufficient Levels of Glutathione?</article-title><source>J. Inherit. Metab. Dis.</source><year>2002</year><volume>25</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1023/A:1022095324407</pub-id><pub-id pub-id-type="pmid">12638941</pub-id>
</element-citation>
      </ref>
      <ref id="B130-biomolecules-14-00206">
        <label>130.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>Z.Z.</given-names></name>
<name><surname>Osei-Frimpong</surname><given-names>J.</given-names></name>
<name><surname>Kala</surname><given-names>G.</given-names></name>
<name><surname>Kala</surname><given-names>S.V.</given-names></name>
<name><surname>Barrios</surname><given-names>R.J.</given-names></name>
<name><surname>Habib</surname><given-names>G.M.</given-names></name>
<name><surname>Lukin</surname><given-names>D.J.</given-names></name>
<name><surname>Danney</surname><given-names>C.M.</given-names></name>
<name><surname>Matzuk</surname><given-names>M.M.</given-names></name>
<name><surname>Lieberman</surname><given-names>M.W.</given-names></name>
</person-group><article-title>Glutathione Synthesis Is Essential for Mouse Development but Not for Cell Growth in Culture</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>5101</fpage><lpage>5106</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.10.5101</pub-id><pub-id pub-id-type="pmid">10805773</pub-id>
</element-citation>
      </ref>
      <ref id="B131-biomolecules-14-00206">
        <label>131.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dalton</surname><given-names>T.P.</given-names></name>
<name><surname>Dieter</surname><given-names>M.Z.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Shertzer</surname><given-names>H.G.</given-names></name>
<name><surname>Nebert</surname><given-names>D.W.</given-names></name>
</person-group><article-title>Knockout of the Mouse Glutamate Cysteine Ligase Catalytic Subunit (<italic toggle="yes">Gclc</italic>) Gene: Embryonic Lethal When Homozygous, and Proposed Model for Moderate Glutathione Deficiency When Heterozygous</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2000</year><volume>279</volume><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.3930</pub-id><pub-id pub-id-type="pmid">11118286</pub-id>
</element-citation>
      </ref>
      <ref id="B132-biomolecules-14-00206">
        <label>132.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winkler</surname><given-names>A.</given-names></name>
<name><surname>Nj&#xE5;lsson</surname><given-names>R.</given-names></name>
<name><surname>Carlsson</surname><given-names>K.</given-names></name>
<name><surname>Elgadi</surname><given-names>A.</given-names></name>
<name><surname>Rozell</surname><given-names>B.</given-names></name>
<name><surname>Abraham</surname><given-names>L.</given-names></name>
<name><surname>Ercal</surname><given-names>N.</given-names></name>
<name><surname>Shi</surname><given-names>Z.-Z.</given-names></name>
<name><surname>Lieberman</surname><given-names>M.W.</given-names></name>
<name><surname>Larsson</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Glutathione Is Essential for Early Embryogenesis--Analysis of a Glutathione Synthetase Knockout Mouse</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2011</year><volume>412</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.07.056</pub-id><pub-id pub-id-type="pmid">21802407</pub-id>
</element-citation>
      </ref>
      <ref id="B133-biomolecules-14-00206">
        <label>133.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsui</surname><given-names>M.</given-names></name>
<name><surname>Oshima</surname><given-names>M.</given-names></name>
<name><surname>Oshima</surname><given-names>H.</given-names></name>
<name><surname>Takaku</surname><given-names>K.</given-names></name>
<name><surname>Maruyama</surname><given-names>T.</given-names></name>
<name><surname>Yodoi</surname><given-names>J.</given-names></name>
<name><surname>Taketo</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Early Embryonic Lethality Caused by Targeted Disruption of the Mouse Thioredoxin Gene</article-title><source>Dev. Biol.</source><year>1996</year><volume>178</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1006/dbio.1996.0208</pub-id><pub-id pub-id-type="pmid">8812119</pub-id>
</element-citation>
      </ref>
      <ref id="B134-biomolecules-14-00206">
        <label>134.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nonn</surname><given-names>L.</given-names></name>
<name><surname>Williams</surname><given-names>R.R.</given-names></name>
<name><surname>Erickson</surname><given-names>R.P.</given-names></name>
<name><surname>Powis</surname><given-names>G.</given-names></name>
</person-group><article-title>The Absence of Mitochondrial Thioredoxin 2 Causes Massive Apoptosis, Exencephaly, and Early Embryonic Lethality in Homozygous Mice</article-title><source>Mol. Cell. Biol.</source><year>2003</year><volume>23</volume><fpage>916</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.3.916-922.2003</pub-id><pub-id pub-id-type="pmid">12529397</pub-id>
</element-citation>
      </ref>
      <ref id="B135-biomolecules-14-00206">
        <label>135.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Holzerova</surname><given-names>E.</given-names></name>
<name><surname>Danhauser</surname><given-names>K.</given-names></name>
<name><surname>Haack</surname><given-names>T.B.</given-names></name>
<name><surname>Kremer</surname><given-names>L.S.</given-names></name>
<name><surname>Melcher</surname><given-names>M.</given-names></name>
<name><surname>Ingold</surname><given-names>I.</given-names></name>
<name><surname>Kobayashi</surname><given-names>S.</given-names></name>
<name><surname>Terrile</surname><given-names>C.</given-names></name>
<name><surname>Wolf</surname><given-names>P.</given-names></name>
<name><surname>Schaper</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Human Thioredoxin 2 Deficiency Impairs Mitochondrial Redox Homeostasis and Causes Early-Onset Neurodegeneration</article-title><source>Brain</source><year>2016</year><volume>139</volume><fpage>346</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1093/brain/awv350</pub-id><pub-id pub-id-type="pmid">26626369</pub-id>
</element-citation>
      </ref>
      <ref id="B136-biomolecules-14-00206">
        <label>136.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pretsch</surname><given-names>W.</given-names></name>
</person-group><article-title>Glutathione Reductase Activity Deficiency in Homozygous Gr1a1Neu Mice Does Not Cause Haemolytic Anaemia</article-title><source>Genet. Res.</source><year>1999</year><volume>73</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1017/S0016672398003590</pub-id><pub-id pub-id-type="pmid">10218442</pub-id>
</element-citation>
      </ref>
      <ref id="B137-biomolecules-14-00206">
        <label>137.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogers</surname><given-names>L.K.</given-names></name>
<name><surname>Tamura</surname><given-names>T.</given-names></name>
<name><surname>Rogers</surname><given-names>B.J.</given-names></name>
<name><surname>Welty</surname><given-names>S.E.</given-names></name>
<name><surname>Hansen</surname><given-names>T.N.</given-names></name>
<name><surname>Smith</surname><given-names>C.V.</given-names></name>
</person-group><article-title>Analyses of Glutathione Reductase Hypomorphic Mice Indicate a Genetic Knockout</article-title><source>Toxicol. Sci.</source><year>2004</year><volume>82</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfh268</pub-id><pub-id pub-id-type="pmid">15342956</pub-id>
</element-citation>
      </ref>
      <ref id="B138-biomolecules-14-00206">
        <label>138.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loehr</surname><given-names>G.W.</given-names></name>
<name><surname>Waller</surname><given-names>H.D.</given-names></name>
</person-group><article-title>A new enzymopenic hemolytic anemia with glutathione reductase deficiency</article-title><source>Med. Klin.</source><year>1962</year><volume>57</volume><fpage>1521</fpage><lpage>1525</lpage><pub-id pub-id-type="pmid">13931269</pub-id>
</element-citation>
      </ref>
      <ref id="B139-biomolecules-14-00206">
        <label>139.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loos</surname><given-names>H.</given-names></name>
<name><surname>Roos</surname><given-names>D.</given-names></name>
<name><surname>Weening</surname><given-names>R.</given-names></name>
<name><surname>Houwerzijl</surname><given-names>J.</given-names></name>
</person-group><article-title>Familial Deficiency of Glutathione Reductase in Human Blood Cells</article-title><source>Blood</source><year>1976</year><volume>48</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1182/blood.V48.1.53.53</pub-id><pub-id pub-id-type="pmid">947404</pub-id>
</element-citation>
      </ref>
      <ref id="B140-biomolecules-14-00206">
        <label>140.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamerbeek</surname><given-names>N.M.</given-names></name>
<name><surname>van Zwieten</surname><given-names>R.</given-names></name>
<name><surname>de Boer</surname><given-names>M.</given-names></name>
<name><surname>Morren</surname><given-names>G.</given-names></name>
<name><surname>Vuil</surname><given-names>H.</given-names></name>
<name><surname>Bannink</surname><given-names>N.</given-names></name>
<name><surname>Lincke</surname><given-names>C.</given-names></name>
<name><surname>Dolman</surname><given-names>K.M.</given-names></name>
<name><surname>Becker</surname><given-names>K.</given-names></name>
<name><surname>Schirmer</surname><given-names>R.H.</given-names></name>
<etal/>
</person-group><article-title>Molecular Basis of Glutathione Reductase Deficiency in Human Blood Cells</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>3560</fpage><lpage>3566</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-08-042531</pub-id><pub-id pub-id-type="pmid">17185460</pub-id>
</element-citation>
      </ref>
      <ref id="B141-biomolecules-14-00206">
        <label>141.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>el-Hazmi</surname><given-names>M.A.</given-names></name>
<name><surname>Warsy</surname><given-names>A.S.</given-names></name>
</person-group><article-title>Glutathione Reductase in the South-Western Province of Saudi Arabia--Genetic Variation vs. Acquired Deficiency</article-title><source>Haematologia</source><year>1989</year><volume>22</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">2707648</pub-id>
</element-citation>
      </ref>
      <ref id="B142-biomolecules-14-00206">
        <label>142.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Warsy</surname><given-names>A.S.</given-names></name>
<name><surname>el-Hazmi</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Glutathione Reductase Deficiency in Saudi Arabia</article-title><source>East. Mediterr. Health J.</source><year>1999</year><volume>5</volume><fpage>1208</fpage><lpage>1212</lpage><pub-id pub-id-type="doi">10.26719/1999.5.6.1208</pub-id><pub-id pub-id-type="pmid">11924113</pub-id>
</element-citation>
      </ref>
      <ref id="B143-biomolecules-14-00206">
        <label>143.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Conrad</surname><given-names>M.</given-names></name>
<name><surname>Bornkamm</surname><given-names>G.W.</given-names></name>
<name><surname>Brielmeier</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Mitochondrial and Cytosolic Thioredoxin Reductase Knockout Mice</article-title>
          <source>Selenium: Its Molecular Biology and Role in Human Health</source>
          <person-group person-group-type="editor">
<name><surname>Hatfield</surname><given-names>D.L.</given-names></name>
<name><surname>Berry</surname><given-names>M.J.</given-names></name>
<name><surname>Gladyshev</surname><given-names>V.N.</given-names></name>
</person-group>
          <publisher-name>Springer</publisher-name>
          <publisher-loc>Boston, MA, USA</publisher-loc>
          <year>2006</year>
          <fpage>195</fpage>
          <lpage>206</lpage>
          <isbn>9780387338279</isbn>
        </element-citation>
      </ref>
      <ref id="B144-biomolecules-14-00206">
        <label>144.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dou</surname><given-names>Q.</given-names></name>
<name><surname>Turanov</surname><given-names>A.A.</given-names></name>
<name><surname>Mariotti</surname><given-names>M.</given-names></name>
<name><surname>Hwang</surname><given-names>J.Y.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Lee</surname><given-names>S.-G.</given-names></name>
<name><surname>Paulo</surname><given-names>J.A.</given-names></name>
<name><surname>Yim</surname><given-names>S.H.</given-names></name>
<name><surname>Gygi</surname><given-names>S.P.</given-names></name>
<name><surname>Chung</surname><given-names>J.-J.</given-names></name>
<etal/>
</person-group><article-title>Selenoprotein TXNRD3 Supports Male Fertility via the Redox Regulation of Spermatogenesis</article-title><source>J. Biol. Chem.</source><year>2022</year><volume>298</volume><elocation-id>102183</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102183</pub-id><pub-id pub-id-type="pmid">35753352</pub-id>
</element-citation>
      </ref>
      <ref id="B145-biomolecules-14-00206">
        <label>145.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maddocks</surname><given-names>O.D.K.</given-names></name>
<name><surname>Labuschagne</surname><given-names>C.F.</given-names></name>
<name><surname>Vousden</surname><given-names>K.H.</given-names></name>
</person-group><article-title>Localization of NADPH Production: A Wheel within a Wheel</article-title><source>Mol. Cell</source><year>2014</year><volume>55</volume><fpage>158</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.07.001</pub-id><pub-id pub-id-type="pmid">25038411</pub-id>
</element-citation>
      </ref>
      <ref id="B146-biomolecules-14-00206">
        <label>146.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Longo</surname><given-names>L.</given-names></name>
<name><surname>Vanegas</surname><given-names>O.C.</given-names></name>
<name><surname>Patel</surname><given-names>M.</given-names></name>
<name><surname>Rosti</surname><given-names>V.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Waka</surname><given-names>J.</given-names></name>
<name><surname>Merghoub</surname><given-names>T.</given-names></name>
<name><surname>Pandolfi</surname><given-names>P.P.</given-names></name>
<name><surname>Notaro</surname><given-names>R.</given-names></name>
<name><surname>Manova</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Maternally Transmitted Severe Glucose 6-Phosphate Dehydrogenase Deficiency Is an Embryonic Lethal</article-title><source>EMBO J.</source><year>2002</year><volume>21</volume><fpage>4229</fpage><lpage>4239</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf426</pub-id><pub-id pub-id-type="pmid">12169625</pub-id>
</element-citation>
      </ref>
      <ref id="B147-biomolecules-14-00206">
        <label>147.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>G&#xF3;mez-Manzo</surname><given-names>S.</given-names></name>
<name><surname>Marcial-Quino</surname><given-names>J.</given-names></name>
<name><surname>Vanoye-Carlo</surname><given-names>A.</given-names></name>
<name><surname>Serrano-Posada</surname><given-names>H.</given-names></name>
<name><surname>Ortega-Cuellar</surname><given-names>D.</given-names></name>
<name><surname>Gonz&#xE1;lez-Valdez</surname><given-names>A.</given-names></name>
<name><surname>Castillo-Rodr&#xED;guez</surname><given-names>R.A.</given-names></name>
<name><surname>Hern&#xE1;ndez-Ochoa</surname><given-names>B.</given-names></name>
<name><surname>Sierra-Palacios</surname><given-names>E.</given-names></name>
<name><surname>Rodr&#xED;guez-Bustamante</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>2069</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17122069</pub-id><pub-id pub-id-type="pmid">27941691</pub-id>
</element-citation>
      </ref>
      <ref id="B148-biomolecules-14-00206">
        <label>148.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cappellini</surname><given-names>M.D.</given-names></name>
<name><surname>Fiorelli</surname><given-names>G.</given-names></name>
</person-group><article-title>Glucose-6-Phosphate Dehydrogenase Deficiency</article-title><source>Lancet</source><year>2008</year><volume>371</volume><fpage>64</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)60073-2</pub-id><pub-id pub-id-type="pmid">18177777</pub-id>
</element-citation>
      </ref>
      <ref id="B149-biomolecules-14-00206">
        <label>149.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luzzatto</surname><given-names>L.</given-names></name>
<name><surname>Arese</surname><given-names>P.</given-names></name>
</person-group><article-title>Favism and Glucose-6-Phosphate Dehydrogenase Deficiency</article-title><source>N. Engl. J. Med.</source><year>2018</year><volume>378</volume><fpage>60</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1708111</pub-id><pub-id pub-id-type="pmid">29298156</pub-id>
</element-citation>
      </ref>
      <ref id="B150-biomolecules-14-00206">
        <label>150.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandolfi</surname><given-names>P.P.</given-names></name>
<name><surname>Sonati</surname><given-names>F.</given-names></name>
<name><surname>Rivi</surname><given-names>R.</given-names></name>
<name><surname>Mason</surname><given-names>P.</given-names></name>
<name><surname>Grosveld</surname><given-names>F.</given-names></name>
<name><surname>Luzzatto</surname><given-names>L.</given-names></name>
</person-group><article-title>Targeted Disruption of the Housekeeping Gene Encoding Glucose 6-Phosphate Dehydrogenase (G6PD): G6PD Is Dispensable for Pentose Synthesis but Essential for Defense against Oxidative Stress</article-title><source>EMBO J.</source><year>1995</year><volume>14</volume><fpage>5209</fpage><lpage>5215</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00205.x</pub-id><pub-id pub-id-type="pmid">7489710</pub-id>
</element-citation>
      </ref>
      <ref id="B151-biomolecules-14-00206">
        <label>151.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brewer</surname><given-names>G.J.</given-names></name>
<name><surname>Dern</surname><given-names>R.J.</given-names></name>
</person-group><article-title>A new inherited enzymatic deficiency of human erythrocytes: 6-phosphogluconate dehydrogenase deficiency</article-title><source>Am. J. Hum. Genet.</source><year>1964</year><volume>16</volume><fpage>472</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">14250427</pub-id>
</element-citation>
      </ref>
      <ref id="B152-biomolecules-14-00206">
        <label>152.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parr</surname><given-names>C.W.</given-names></name>
<name><surname>Fitch</surname><given-names>L.I.</given-names></name>
</person-group><article-title>Inherited Quantitative Variations of Human Phosphogluconate Dehydrogenase</article-title><source>Ann. Hum. Genet.</source><year>1967</year><volume>30</volume><fpage>339</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1111/j.1469-1809.1967.tb00036.x</pub-id><pub-id pub-id-type="pmid">5619935</pub-id>
</element-citation>
      </ref>
      <ref id="B153-biomolecules-14-00206">
        <label>153.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>F.M.</given-names></name>
<name><surname>Chasalow</surname><given-names>F.</given-names></name>
<name><surname>Lewis</surname><given-names>S.E.</given-names></name>
<name><surname>Barnett</surname><given-names>L.</given-names></name>
<name><surname>Lee</surname><given-names>C.-Y.</given-names></name>
</person-group><article-title>A Null Allele at the Mod-1 Locus of the Mouse</article-title><source>J. Hered.</source><year>1981</year><volume>72</volume><fpage>134</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jhered.a109448</pub-id><pub-id pub-id-type="pmid">7276516</pub-id>
</element-citation>
      </ref>
      <ref id="B154-biomolecules-14-00206">
        <label>154.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Deignan</surname><given-names>J.L.</given-names></name>
<name><surname>Qi</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<name><surname>Qian</surname><given-names>S.</given-names></name>
<name><surname>Zhong</surname><given-names>J.</given-names></name>
<name><surname>Torosyan</surname><given-names>G.</given-names></name>
<name><surname>Majid</surname><given-names>S.</given-names></name>
<name><surname>Falkard</surname><given-names>B.</given-names></name>
<name><surname>Kleinhanz</surname><given-names>R.R.</given-names></name>
<etal/>
</person-group><article-title>Validation of Candidate Causal Genes for Obesity That Affect Shared Metabolic Pathways and Networks</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/ng.325</pub-id><pub-id pub-id-type="pmid">19270708</pub-id>
</element-citation>
      </ref>
      <ref id="B155-biomolecules-14-00206">
        <label>155.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>T.J.</given-names></name>
<name><surname>Peterson</surname><given-names>P.E.</given-names></name>
<name><surname>Schmidt</surname><given-names>T.</given-names></name>
<name><surname>Fang</surname><given-names>J.</given-names></name>
<name><surname>Stanley</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Structures of Bovine Glutamate Dehydrogenase Complexes Elucidate the Mechanism of Purine Regulation</article-title><source>J. Mol. Biol.</source><year>2001</year><volume>307</volume><fpage>707</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2001.4499</pub-id><pub-id pub-id-type="pmid">11254391</pub-id>
</element-citation>
      </ref>
      <ref id="B156-biomolecules-14-00206">
        <label>156.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brandt</surname><given-names>A.</given-names></name>
<name><surname>Agarwal</surname><given-names>N.</given-names></name>
<name><surname>Giri</surname><given-names>D.</given-names></name>
<name><surname>Yung</surname><given-names>Z.</given-names></name>
<name><surname>Didi</surname><given-names>M.</given-names></name>
<name><surname>Senniappan</surname><given-names>S.</given-names></name>
</person-group><article-title>Hyperinsulinism Hyperammonaemia (HI/HA) Syndrome due to <italic toggle="yes">GLUD1</italic> Mutation: Phenotypic Variations Ranging from Late Presentation to Spontaneous Resolution</article-title><source>J. Pediatr. Endocrinol. Metab.</source><year>2020</year><volume>33</volume><fpage>675</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1515/jpem-2019-0416</pub-id><pub-id pub-id-type="pmid">32229669</pub-id>
</element-citation>
      </ref>
      <ref id="B157-biomolecules-14-00206">
        <label>157.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Itsumi</surname><given-names>M.</given-names></name>
<name><surname>Inoue</surname><given-names>S.</given-names></name>
<name><surname>Elia</surname><given-names>A.J.</given-names></name>
<name><surname>Murakami</surname><given-names>K.</given-names></name>
<name><surname>Sasaki</surname><given-names>M.</given-names></name>
<name><surname>Lind</surname><given-names>E.F.</given-names></name>
<name><surname>Brenner</surname><given-names>D.</given-names></name>
<name><surname>Harris</surname><given-names>I.S.</given-names></name>
<name><surname>Chio</surname><given-names>I.I.C.</given-names></name>
<name><surname>Afzal</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Idh1 Protects Murine Hepatocytes from Endotoxin-Induced Oxidative Stress by Regulating the Intracellular NADP+/NADPH Ratio</article-title><source>Cell Death Differ.</source><year>2015</year><volume>22</volume><fpage>1837</fpage><lpage>1845</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.38</pub-id><pub-id pub-id-type="pmid">25882048</pub-id>
</element-citation>
      </ref>
      <ref id="B158-biomolecules-14-00206">
        <label>158.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kranendijk</surname><given-names>M.</given-names></name>
<name><surname>Struys</surname><given-names>E.A.</given-names></name>
<name><surname>van Schaftingen</surname><given-names>E.</given-names></name>
<name><surname>Gibson</surname><given-names>K.M.</given-names></name>
<name><surname>Kanhai</surname><given-names>W.A.</given-names></name>
<name><surname>van der Knaap</surname><given-names>M.S.</given-names></name>
<name><surname>Amiel</surname><given-names>J.</given-names></name>
<name><surname>Buist</surname><given-names>N.R.</given-names></name>
<name><surname>Das</surname><given-names>A.M.</given-names></name>
<name><surname>de Klerk</surname><given-names>J.B.</given-names></name>
<etal/>
</person-group><article-title>IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria</article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>336</fpage><pub-id pub-id-type="doi">10.1126/science.1192632</pub-id><pub-id pub-id-type="pmid">20847235</pub-id>
</element-citation>
      </ref>
      <ref id="B159-biomolecules-14-00206">
        <label>159.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ku</surname><given-names>H.J.</given-names></name>
<name><surname>Ahn</surname><given-names>Y.</given-names></name>
<name><surname>Lee</surname><given-names>J.H.</given-names></name>
<name><surname>Park</surname><given-names>K.M.</given-names></name>
<name><surname>Park</surname><given-names>J.-W.</given-names></name>
</person-group><article-title>IDH2 Deficiency Promotes Mitochondrial Dysfunction and Cardiac Hypertrophy in Mice</article-title><source>Free Radic. Biol. Med.</source><year>2015</year><volume>80</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.12.018</pub-id><pub-id pub-id-type="pmid">25557279</pub-id>
</element-citation>
      </ref>
      <ref id="B160-biomolecules-14-00206">
        <label>160.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>White</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>M.-J.</given-names></name>
<name><surname>Han</surname><given-names>C.</given-names></name>
<name><surname>Park</surname><given-names>H.-J.</given-names></name>
<name><surname>Ding</surname><given-names>D.</given-names></name>
<name><surname>Boyd</surname><given-names>K.</given-names></name>
<name><surname>Walker</surname><given-names>L.</given-names></name>
<name><surname>Linser</surname><given-names>P.</given-names></name>
<name><surname>Meneses</surname><given-names>Z.</given-names></name>
<name><surname>Slade</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Loss of IDH2 Accelerates Age-Related Hearing Loss in Male Mice</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>5039</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-23436-w</pub-id><pub-id pub-id-type="pmid">29567975</pub-id>
</element-citation>
      </ref>
      <ref id="B161-biomolecules-14-00206">
        <label>161.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fan</surname><given-names>J.</given-names></name>
<name><surname>Ye</surname><given-names>J.</given-names></name>
<name><surname>Kamphorst</surname><given-names>J.J.</given-names></name>
<name><surname>Shlomi</surname><given-names>T.</given-names></name>
<name><surname>Thompson</surname><given-names>C.B.</given-names></name>
<name><surname>Rabinowitz</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Quantitative Flux Analysis Reveals Folate-Dependent NADPH Production</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1038/nature13236</pub-id><pub-id pub-id-type="pmid">24805240</pub-id>
</element-citation>
      </ref>
      <ref id="B162-biomolecules-14-00206">
        <label>162.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>C.A.</given-names></name>
<name><surname>Parker</surname><given-names>S.J.</given-names></name>
<name><surname>Fiske</surname><given-names>B.P.</given-names></name>
<name><surname>McCloskey</surname><given-names>D.</given-names></name>
<name><surname>Gui</surname><given-names>D.Y.</given-names></name>
<name><surname>Green</surname><given-names>C.R.</given-names></name>
<name><surname>Vokes</surname><given-names>N.I.</given-names></name>
<name><surname>Feist</surname><given-names>A.M.</given-names></name>
<name><surname>Vander Heiden</surname><given-names>M.G.</given-names></name>
<name><surname>Metallo</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells</article-title><source>Mol. Cell</source><year>2014</year><volume>55</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.05.008</pub-id><pub-id pub-id-type="pmid">24882210</pub-id>
</element-citation>
      </ref>
      <ref id="B163-biomolecules-14-00206">
        <label>163.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hum</surname><given-names>D.W.</given-names></name>
<name><surname>Bell</surname><given-names>A.W.</given-names></name>
<name><surname>Rozen</surname><given-names>R.</given-names></name>
<name><surname>MacKenzie</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Primary Structure of a Human Trifunctional Enzyme. Isolation of a cDNA Encoding Methylenetetrahydrofolate Dehydrogenase-Methenyltetrahydrofolate Cyclohydrolase-Formyltetrahydrofolate Synthetase</article-title><source>J. Biol. Chem.</source><year>1988</year><volume>263</volume><fpage>15946</fpage><lpage>15950</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)37540-9</pub-id><pub-id pub-id-type="pmid">3053686</pub-id>
</element-citation>
      </ref>
      <ref id="B164-biomolecules-14-00206">
        <label>164.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Pietro</surname><given-names>E.</given-names></name>
<name><surname>Sirois</surname><given-names>J.</given-names></name>
<name><surname>Tremblay</surname><given-names>M.L.</given-names></name>
<name><surname>MacKenzie</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Mitochondrial NAD-Dependent Methylenetetrahydrofolate Dehydrogenase-Methenyltetrahydrofolate Cyclohydrolase Is Essential for Embryonic Development</article-title><source>Mol. Cell. Biol.</source><year>2002</year><volume>22</volume><fpage>4158</fpage><lpage>4166</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.12.4158-4166.2002</pub-id><pub-id pub-id-type="pmid">12024029</pub-id>
</element-citation>
      </ref>
      <ref id="B165-biomolecules-14-00206">
        <label>165.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>MacFarlane</surname><given-names>A.J.</given-names></name>
<name><surname>Perry</surname><given-names>C.A.</given-names></name>
<name><surname>Girnary</surname><given-names>H.H.</given-names></name>
<name><surname>Gao</surname><given-names>D.</given-names></name>
<name><surname>Allen</surname><given-names>R.H.</given-names></name>
<name><surname>Stabler</surname><given-names>S.P.</given-names></name>
<name><surname>Shane</surname><given-names>B.</given-names></name>
<name><surname>Stover</surname><given-names>P.J.</given-names></name>
</person-group><article-title><italic toggle="yes">Mthfd1</italic> Is an Essential Gene in Mice and Alters Biomarkers of Impaired One-Carbon Metabolism</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>1533</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1074/jbc.M808281200</pub-id><pub-id pub-id-type="pmid">19033438</pub-id>
</element-citation>
      </ref>
      <ref id="B166-biomolecules-14-00206">
        <label>166.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watkins</surname><given-names>D.</given-names></name>
<name><surname>Schwartzentruber</surname><given-names>J.A.</given-names></name>
<name><surname>Ganesh</surname><given-names>J.</given-names></name>
<name><surname>Orange</surname><given-names>J.S.</given-names></name>
<name><surname>Kaplan</surname><given-names>B.S.</given-names></name>
<name><surname>Nunez</surname><given-names>L.D.</given-names></name>
<name><surname>Majewski</surname><given-names>J.</given-names></name>
<name><surname>Rosenblatt</surname><given-names>D.S.</given-names></name>
</person-group><article-title>Novel Inborn Error of Folate Metabolism: Identification by Exome Capture and Sequencing of Mutations in the <italic toggle="yes">MTHFD1</italic> Gene in a Single Proband</article-title><source>J. Med. Genet.</source><year>2011</year><volume>48</volume><fpage>590</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100286</pub-id><pub-id pub-id-type="pmid">21813566</pub-id>
</element-citation>
      </ref>
      <ref id="B167-biomolecules-14-00206">
        <label>167.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>M.D.</given-names></name>
<name><surname>Ganesh</surname><given-names>J.</given-names></name>
<name><surname>Heltzer</surname><given-names>M.</given-names></name>
<name><surname>Paessler</surname><given-names>M.</given-names></name>
<name><surname>Bergqvist</surname><given-names>A.G.C.</given-names></name>
<name><surname>Baluarte</surname><given-names>H.J.</given-names></name>
<name><surname>Watkins</surname><given-names>D.</given-names></name>
<name><surname>Rosenblatt</surname><given-names>D.S.</given-names></name>
<name><surname>Orange</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Severe Combined Immunodeficiency Resulting from Mutations in <italic toggle="yes">MTHFD1</italic></article-title><source>Pediatrics</source><year>2013</year><volume>131</volume><fpage>e629</fpage><lpage>e634</lpage><pub-id pub-id-type="doi">10.1542/peds.2012-0899</pub-id><pub-id pub-id-type="pmid">23296427</pub-id>
</element-citation>
      </ref>
      <ref id="B168-biomolecules-14-00206">
        <label>168.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burda</surname><given-names>P.</given-names></name>
<name><surname>Kuster</surname><given-names>A.</given-names></name>
<name><surname>Hjalmarson</surname><given-names>O.</given-names></name>
<name><surname>Suormala</surname><given-names>T.</given-names></name>
<name><surname>B&#xFC;rer</surname><given-names>C.</given-names></name>
<name><surname>Lutz</surname><given-names>S.</given-names></name>
<name><surname>Roussey</surname><given-names>G.</given-names></name>
<name><surname>Christa</surname><given-names>L.</given-names></name>
<name><surname>Asin-Cayuela</surname><given-names>J.</given-names></name>
<name><surname>Kollberg</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Characterization and Review of MTHFD1 Deficiency: Four New Patients, Cellular Delineation and Response to Folic and Folinic Acid Treatment</article-title><source>J. Inherit. Metab. Dis.</source><year>2015</year><volume>38</volume><fpage>863</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1007/s10545-015-9810-3</pub-id><pub-id pub-id-type="pmid">25633902</pub-id>
</element-citation>
      </ref>
      <ref id="B169-biomolecules-14-00206">
        <label>169.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anguera</surname><given-names>M.C.</given-names></name>
<name><surname>Field</surname><given-names>M.S.</given-names></name>
<name><surname>Perry</surname><given-names>C.</given-names></name>
<name><surname>Ghandour</surname><given-names>H.</given-names></name>
<name><surname>Chiang</surname><given-names>E.-P.</given-names></name>
<name><surname>Selhub</surname><given-names>J.</given-names></name>
<name><surname>Shane</surname><given-names>B.</given-names></name>
<name><surname>Stover</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Regulation of Folate-Mediated One-Carbon Metabolism by 10-Formyltetrahydrofolate Dehydrogenase</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>18335</fpage><lpage>18342</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510623200</pub-id><pub-id pub-id-type="pmid">16627483</pub-id>
</element-citation>
      </ref>
      <ref id="B170-biomolecules-14-00206">
        <label>170.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strickland</surname><given-names>K.C.</given-names></name>
<name><surname>Krupenko</surname><given-names>N.I.</given-names></name>
<name><surname>Dubard</surname><given-names>M.E.</given-names></name>
<name><surname>Hu</surname><given-names>C.J.</given-names></name>
<name><surname>Tsybovsky</surname><given-names>Y.</given-names></name>
<name><surname>Krupenko</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Enzymatic Properties of ALDH1L2, a Mitochondrial 10-Formyltetrahydrofolate Dehydrogenase</article-title><source>Chem. Biol. Interact.</source><year>2011</year><volume>191</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2011.01.008</pub-id><pub-id pub-id-type="pmid">21238436</pub-id>
</element-citation>
      </ref>
      <ref id="B171-biomolecules-14-00206">
        <label>171.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>J.</given-names></name>
<name><surname>Krupenko</surname><given-names>N.I.</given-names></name>
<name><surname>Krupenko</surname><given-names>S.A.</given-names></name>
</person-group>
          <article-title>Impact of Aldh1l1 Knockout on Metabolic Phenotype in Mouse Liver</article-title>
          <source>FASEB J.</source>
          <year>2019</year>
          <volume>33</volume>
          <fpage>lb249</fpage>
          <pub-id pub-id-type="doi">10.1096/fasebj.2019.33.1_supplement.lb249</pub-id>
        </element-citation>
      </ref>
      <ref id="B172-biomolecules-14-00206">
        <label>172.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sarret</surname><given-names>C.</given-names></name>
<name><surname>Ashkavand</surname><given-names>Z.</given-names></name>
<name><surname>Paules</surname><given-names>E.</given-names></name>
<name><surname>Dorboz</surname><given-names>I.</given-names></name>
<name><surname>Pediaditakis</surname><given-names>P.</given-names></name>
<name><surname>Sumner</surname><given-names>S.</given-names></name>
<name><surname>Eymard-Pierre</surname><given-names>E.</given-names></name>
<name><surname>Francannet</surname><given-names>C.</given-names></name>
<name><surname>Krupenko</surname><given-names>N.I.</given-names></name>
<name><surname>Boespflug-Tanguy</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>Deleterious Mutations in <italic toggle="yes">ALDH1L2</italic> Suggest a Novel Cause for Neuro-Ichthyotic Syndrome</article-title><source>NPJ Genom. Med.</source><year>2019</year><volume>4</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1038/s41525-019-0092-9</pub-id><pub-id pub-id-type="pmid">31341639</pub-id>
</element-citation>
      </ref>
      <ref id="B173-biomolecules-14-00206">
        <label>173.</label>
        <element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krupenko</surname><given-names>N.I.</given-names></name>
<name><surname>Sharma</surname><given-names>J.</given-names></name>
<name><surname>Pediaditakis</surname><given-names>P.</given-names></name>
<name><surname>Helke</surname><given-names>K.L.</given-names></name>
<name><surname>Hall</surname><given-names>M.S.</given-names></name>
<name><surname>Du</surname><given-names>X.</given-names></name>
<name><surname>Sumner</surname><given-names>S.</given-names></name>
<name><surname>Krupenko</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Aldh1l2 Knockout Mouse Metabolomics Links the Loss of the Mitochondrial Folate Enzyme to Deregulation of a Lipid Metabolism Observed in Rare Human Disorder</article-title><source>Hum. Genom.</source><year>2020</year><volume>14</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s40246-020-00291-3</pub-id><pub-id pub-id-type="pmid">33168096</pub-id>
</element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig position="float" id="biomolecules-14-00206-f001">
      <label>Figure 1</label>
      <caption>
        <p>Schematic overview of ROS production sites and reactions. Several enzymatic reactions as well as interactions of iron with oxygen give rise to reactive oxygen species. Their localization and production level can differ between cell compartments and cell types. For example, red blood cells experience high levels of superoxide due to their heme-bound iron (Fe<sup>2</sup>+) and oxygen interaction, whereas the mitochondrial electron transport chain is a major source of ROS in other cells. Under ischemic conditions, xanthine oxidase (XOD) produces superoxide anions (O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in the cytosol. NADPH oxidases (NOX) mainly produce O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup> to kill pathogens in the phagosome or extracellular space. Similarly, myeloperoxidase (MPO) produces hypochlorous acid (HOCl<sup>.</sup>) from H<sub>2</sub>O<sub>2</sub> which derives from NOX-produced O<sub>2</sub><sup>&#xB7;&#x2212;</sup> in phagosomes and neutrophil extracellular traps (NETs). Instead, nitric oxide synthases (NOS) normally produce nitric oxide (<sup>.</sup>NO) as a signaling molecule. Depletion of its substrate arginine or cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (BH<sub>4</sub>) can cause the enzyme to uncouple and produce O<sub>2</sub><bold><sup>&#xB7;</sup></bold><sup>&#x2212;</sup>.</p>
      </caption>
      <graphic xlink:href="biomolecules-14-00206-g001" position="float"/>
    </fig>
    <fig position="float" id="biomolecules-14-00206-f002">
      <label>Figure 2</label>
      <caption>
        <p>The cellular anti-oxidative machinery. Oxidative stress from exogenous or endogenous sources would damage biomolecules and cause disease if not counteracted by a set of direct enzymatic (SOD, CAT, GSX) and non-enzymatic (GSH, TXN) anti-oxidative molecular systems that are regenerated by different reductases (TXNR, GSR).</p>
      </caption>
      <graphic xlink:href="biomolecules-14-00206-g002" position="float"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>